Engineering adeno-associated virus vectors for gene therapy
Adeno-associated virus (AAV) vector-mediated gene delivery was recently approved for the treatment of inherited blindness and spinal muscular atrophy, and long-term therapeutic effects have been achieved for other rare diseases, including haemophilia and Duchenne muscular dystrophy. However, current...
Uloženo v:
| Vydáno v: | Nature reviews. Genetics Ročník 21; číslo 4; s. 255 - 272 |
|---|---|
| Hlavní autoři: | , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
London
Nature Publishing Group UK
01.04.2020
Nature Publishing Group |
| Témata: | |
| ISSN: | 1471-0056, 1471-0064, 1471-0064 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | Adeno-associated virus (AAV) vector-mediated gene delivery was recently approved for the treatment of inherited blindness and spinal muscular atrophy, and long-term therapeutic effects have been achieved for other rare diseases, including haemophilia and Duchenne muscular dystrophy. However, current research indicates that the genetic modification of AAV vectors may further facilitate the success of AAV gene therapy. Vector engineering can increase AAV transduction efficiency (by optimizing the transgene cassette), vector tropism (using capsid engineering) and the ability of the capsid and transgene to avoid the host immune response (by genetically modifying these components), as well as optimize the large-scale production of AAV.
Adeno-associated virus (AAV) vector-mediated gene delivery has had long-term therapeutic effects for several diseases, including haemophilia and Duchenne muscular dystrophy. Genetically modifying AAV vectors to increase their transduction efficiency, vector tropism and ability to avoid the host immune response may further increase the success of AAV gene therapy. |
|---|---|
| AbstractList | Adeno-associated virus (AAV) vector-mediated gene delivery was recently approved for the treatment of inherited blindness and spinal muscular atrophy, and long-term therapeutic effects have been achieved for other rare diseases, including haemophilia and Duchenne muscular dystrophy. However, current research indicates that the genetic modification of AAV vectors may further facilitate the success of AAV gene therapy. Vector engineering can increase AAV transduction efficiency (by optimizing the transgene cassette), vector tropism (using capsid engineering) and the ability of the capsid and transgene to avoid the host immune response (by genetically modifying these components), as well as optimize the large-scale production of AAV. Adeno-associated virus (AAV) vector-mediated gene delivery has had long-term therapeutic effects for several diseases, including haemophilia and Duchenne muscular dystrophy. Genetically modifying AAV vectors to increase their transduction efficiency, vector tropism and ability to avoid the host immune response may further increase the success of AAV gene therapy. Adeno-associated virus (AAV) vector-mediated gene delivery was recently approved for the treatment of inherited blindness and spinal muscular atrophy, and long-term therapeutic effects have been achieved for other rare diseases, including haemophilia and Duchenne muscular dystrophy. However, current research indicates that the genetic modification of AAV vectors may further facilitate the success of AAV gene therapy. Vector engineering can increase AAV transduction efficiency (by optimizing the transgene cassette), vector tropism (using capsid engineering) and the ability of the capsid and transgene to avoid the host immune response (by genetically modifying these components), as well as optimize the large-scale production of AAV. Adeno-associated virus (AAV) vector-mediated gene delivery was recently approved for the treatment of inherited blindness and spinal muscular atrophy, and long-term therapeutic effects have been achieved for other rare diseases, including haemophilia and Duchenne muscular dystrophy. However, current research indicates that the genetic modification of AAV vectors may further facilitate the success of AAV gene therapy. Vector engineering can increase AAV transduction efficiency (by optimizing the transgene cassette), vector tropism (using capsid engineering) and the ability of the capsid and transgene to avoid the host immune response (by genetically modifying these components), as well as optimize the large-scale production of AAV. Adeno-associated virus (AAV) vector-mediated gene delivery has had long-term therapeutic effects for several diseases, including haemophilia and Duchenne muscular dystrophy. Genetically modifying AAV vectors to increase their transduction efficiency, vector tropism and ability to avoid the host immune response may further increase the success of AAV gene therapy. Adeno-associated virus (AAV) vector-mediated gene delivery was recently approved for the treatment of inherited blindness and spinal muscular atrophy, and long-term therapeutic effects have been achieved for other rare diseases, including haemophilia and Duchenne muscular dystrophy. However, current research indicates that the genetic modification of AAV vectors may further facilitate the success of AAV gene therapy. Vector engineering can increase AAV transduction efficiency (by optimizing the transgene cassette), vector tropism (using capsid engineering) and the ability of the capsid and transgene to avoid the host immune response (by genetically modifying these components), as well as optimize the large-scale production of AAV.Adeno-associated virus (AAV) vector-mediated gene delivery was recently approved for the treatment of inherited blindness and spinal muscular atrophy, and long-term therapeutic effects have been achieved for other rare diseases, including haemophilia and Duchenne muscular dystrophy. However, current research indicates that the genetic modification of AAV vectors may further facilitate the success of AAV gene therapy. Vector engineering can increase AAV transduction efficiency (by optimizing the transgene cassette), vector tropism (using capsid engineering) and the ability of the capsid and transgene to avoid the host immune response (by genetically modifying these components), as well as optimize the large-scale production of AAV. |
| Audience | Academic |
| Author | Samulski, R. Jude Li, Chengwen |
| Author_xml | – sequence: 1 givenname: Chengwen surname: Li fullname: Li, Chengwen email: chengwen@med.unc.edu organization: Gene Therapy Center, University of North Carolina at Chapel Hill, Department of Pediatrics, University of North Carolina at Chapel Hill – sequence: 2 givenname: R. Jude surname: Samulski fullname: Samulski, R. Jude email: rjs@med.unc.edu organization: Gene Therapy Center, University of North Carolina at Chapel Hill, Department of Pharmacology, University of North Carolina at Chapel Hill |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32042148$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kltrFTEQx4NU7EU_gC-yIIg-bM1skk0Wn0qptVAQvDyHnOzsOSl7kmOSLfbbm-X04ila8pALv_9MZuZ_SPZ88EjIa6DHQJn6mDgI2dYUupo2VNT8GTkALqGmtOV792fR7pPDlK4ohRYke0H2WUN5A1wdkE9nfuk8YnR-WZkefahNSsE6k7Gvrl2cUnWNNoeYqiHEaokeq7zCaDY3L8nzwYwJX93uR-Tn57Mfp1_qy6_nF6cnl7UVncq1scAQF1y2slemHzo-SFh0VnGAwTRclRsqKZgVCoEpaXnPhbRS9i2wxrIj8n4bdxPDrwlT1muXLI6j8RimpBsmmFCgaFfQt4_QqzBFX36nGy55p1rG-ZMUk53gpVHtA7U0I2rnh5CjsXNqfdKCaoQsKQt1_A-qrB7XzpZ5Da687wg-7AgKk_F3XpopJX3x_dsu--4vdoVmzKsUxim74NMu-Oa2ommxxl5volubeKPvBl0A2AI2hpQiDvcIUD2bSW_NpIuZ9GwmPbdJPtJYl82cu5ToxieVzVaZNrOxMD40-P-iP9v41vY |
| CitedBy_id | crossref_primary_10_1002_smll_202204139 crossref_primary_10_1089_hum_2020_069 crossref_primary_10_1134_S0006297924604659 crossref_primary_10_3389_fneur_2021_745159 crossref_primary_10_3390_cells10061470 crossref_primary_10_1007_s40259_024_00654_5 crossref_primary_10_1002_mog2_55 crossref_primary_10_1007_s12264_022_00949_z crossref_primary_10_1038_s41598_022_12404_0 crossref_primary_10_1186_s12985_024_02286_1 crossref_primary_10_3389_fncel_2021_661857 crossref_primary_10_1016_j_omtm_2023_101124 crossref_primary_10_3390_ijms24097736 crossref_primary_10_1039_D1NR04153C crossref_primary_10_1016_j_omtm_2023_101129 crossref_primary_10_1007_s11064_022_03803_w crossref_primary_10_3389_fbioe_2023_1164252 crossref_primary_10_3390_ijms231810228 crossref_primary_10_1016_j_hlc_2023_02_011 crossref_primary_10_1155_2024_6638269 crossref_primary_10_3389_fgeed_2023_1148693 crossref_primary_10_1016_j_isci_2024_109777 crossref_primary_10_1089_hum_2020_053 crossref_primary_10_1021_acschemneuro_5c00404 crossref_primary_10_1016_j_apsb_2023_06_006 crossref_primary_10_1016_j_jviromet_2023_114688 crossref_primary_10_1007_s00395_020_00839_3 crossref_primary_10_1186_s12929_023_00989_1 crossref_primary_10_1016_j_biomaterials_2023_122335 crossref_primary_10_3390_v16030442 crossref_primary_10_1002_mabi_202400043 crossref_primary_10_1038_s41569_024_01001_5 crossref_primary_10_1016_j_omtm_2023_101136 crossref_primary_10_1016_j_cellsig_2025_111856 crossref_primary_10_1016_j_addr_2021_01_017 crossref_primary_10_1016_j_neurol_2021_06_006 crossref_primary_10_1002_jcsm_12760 crossref_primary_10_3390_v16111794 crossref_primary_10_3390_cells12050785 crossref_primary_10_1128_jvi_00633_24 crossref_primary_10_1186_s12943_021_01346_2 crossref_primary_10_1007_s00431_025_06426_9 crossref_primary_10_1111_cpr_13565 crossref_primary_10_1002_bit_28562 crossref_primary_10_1186_s12985_021_01715_9 crossref_primary_10_1016_j_biopha_2024_116148 crossref_primary_10_1089_hum_2020_169 crossref_primary_10_1016_j_ymthe_2024_04_030 crossref_primary_10_1016_j_jim_2022_113397 crossref_primary_10_1039_D0BM01367F crossref_primary_10_1007_s12264_023_01130_w crossref_primary_10_1111_cpr_70127 crossref_primary_10_1016_j_jddst_2021_102551 crossref_primary_10_1016_j_phrs_2021_105807 crossref_primary_10_1016_j_dmpk_2022_100483 crossref_primary_10_1016_j_gene_2021_145889 crossref_primary_10_3389_fnins_2024_1272786 crossref_primary_10_17116_jnevro202312303134 crossref_primary_10_1128_JVI_01604_20 crossref_primary_10_3390_medicina60101647 crossref_primary_10_1016_j_nantod_2022_101482 crossref_primary_10_1016_j_omto_2021_01_010 crossref_primary_10_1038_s41416_021_01353_6 crossref_primary_10_3390_biomedicines10030648 crossref_primary_10_1111_cpr_13680 crossref_primary_10_1002_cpt_2224 crossref_primary_10_1002_advs_202308095 crossref_primary_10_3390_jcm14113827 crossref_primary_10_1002_adfm_202402630 crossref_primary_10_1128_JVI_00587_21 crossref_primary_10_3390_pharmaceutics16020288 crossref_primary_10_3390_ijms26094420 crossref_primary_10_1182_bloodadvances_2023011847 crossref_primary_10_1007_s12274_024_6748_5 crossref_primary_10_1038_s12276_024_01251_w crossref_primary_10_1016_j_omtn_2021_01_003 crossref_primary_10_1016_j_omton_2025_201020 crossref_primary_10_3389_fmed_2023_1106085 crossref_primary_10_1016_j_omtm_2022_03_017 crossref_primary_10_1016_j_ymthe_2023_09_019 crossref_primary_10_1007_s11265_022_01758_3 crossref_primary_10_1016_j_omtn_2022_03_017 crossref_primary_10_1016_j_apsb_2025_03_033 crossref_primary_10_3389_fmed_2023_1190016 crossref_primary_10_1038_s41586_022_04533_3 crossref_primary_10_1016_j_omtm_2022_03_016 crossref_primary_10_1016_j_omtm_2023_101115 crossref_primary_10_1016_j_yjmcc_2023_03_002 crossref_primary_10_1016_j_jtcvs_2022_08_050 crossref_primary_10_1038_s41467_022_33745_4 crossref_primary_10_1126_scitranslmed_abn9074 crossref_primary_10_1002_iub_2896 crossref_primary_10_1038_s41392_023_01680_5 crossref_primary_10_1038_s41592_025_02609_2 crossref_primary_10_1088_1758_5090_add625 crossref_primary_10_3389_fcell_2025_1547523 crossref_primary_10_1002_bit_28500 crossref_primary_10_1128_JVI_00976_20 crossref_primary_10_3389_fmed_2022_859930 crossref_primary_10_1093_eurheartj_ehaf411 crossref_primary_10_26508_lsa_202101040 crossref_primary_10_3390_biomedicines12061159 crossref_primary_10_1016_j_bioactmat_2022_08_013 crossref_primary_10_1016_j_omtm_2022_11_003 crossref_primary_10_3390_ijms241311033 crossref_primary_10_1016_j_ymthe_2020_12_007 crossref_primary_10_1177_01926233211041962 crossref_primary_10_1128_JVI_00773_21 crossref_primary_10_1016_j_biopha_2022_112677 crossref_primary_10_1007_s13402_025_01056_7 crossref_primary_10_3390_ijms221810025 crossref_primary_10_1007_s12519_022_00669_4 crossref_primary_10_1039_D4NR01300J crossref_primary_10_1016_j_heares_2023_108735 crossref_primary_10_1007_s10529_023_03422_7 crossref_primary_10_3390_pharmaceutics16091207 crossref_primary_10_1016_j_omtm_2024_101326 crossref_primary_10_1158_2326_6066_CIR_22_0439 crossref_primary_10_1016_j_omtm_2020_05_019 crossref_primary_10_2174_0113816128286593240226060318 crossref_primary_10_1016_j_omtm_2024_101201 crossref_primary_10_1038_s41392_024_01750_2 crossref_primary_10_1038_s41577_025_01174_1 crossref_primary_10_1016_j_mam_2025_101400 crossref_primary_10_1038_s41434_022_00360_3 crossref_primary_10_3390_jcm13185647 crossref_primary_10_1128_JVI_02023_20 crossref_primary_10_3389_fneur_2022_870799 crossref_primary_10_3390_molecules29184405 crossref_primary_10_1016_j_ymthe_2025_04_027 crossref_primary_10_3389_fmed_2022_880763 crossref_primary_10_1038_s41467_022_33523_2 crossref_primary_10_1186_s13287_020_01950_x crossref_primary_10_7759_cureus_42614 crossref_primary_10_1016_j_jpba_2023_115562 crossref_primary_10_3390_genes14101866 crossref_primary_10_1089_hum_2021_083 crossref_primary_10_3390_biom11081135 crossref_primary_10_1016_j_celbio_2025_100143 crossref_primary_10_1038_s41392_022_01158_w crossref_primary_10_1016_j_jddst_2021_102728 crossref_primary_10_2217_nnm_2023_0156 crossref_primary_10_1016_j_jtha_2024_07_012 crossref_primary_10_3389_fgeed_2020_609650 crossref_primary_10_3390_ijms241512434 crossref_primary_10_1016_j_stem_2022_11_012 crossref_primary_10_1016_j_omtm_2023_101143 crossref_primary_10_3390_ijms22115494 crossref_primary_10_1016_j_cellimm_2024_104806 crossref_primary_10_1016_j_omtm_2021_07_001 crossref_primary_10_1002_btm2_10258 crossref_primary_10_3389_fcell_2021_693694 crossref_primary_10_1111_jvh_13915 crossref_primary_10_1016_j_ynirp_2024_100218 crossref_primary_10_1016_j_molmet_2022_101474 crossref_primary_10_1097_ICU_0000000000001025 crossref_primary_10_1002_bit_70013 crossref_primary_10_1016_j_biopha_2021_112061 crossref_primary_10_1016_j_omtm_2023_101147 crossref_primary_10_1096_fj_201902875R crossref_primary_10_1016_j_biomaterials_2021_120965 crossref_primary_10_1016_j_isci_2024_111207 crossref_primary_10_1089_scd_2022_0242 crossref_primary_10_3389_fcvm_2022_952755 crossref_primary_10_1186_s13036_024_00409_4 crossref_primary_10_1016_j_addr_2022_114161 crossref_primary_10_1038_s41417_021_00413_6 crossref_primary_10_3390_ijms22084116 crossref_primary_10_3390_jcm10112471 crossref_primary_10_1002_bit_28412 crossref_primary_10_1016_j_copbio_2021_12_009 crossref_primary_10_1038_s42003_023_04851_w crossref_primary_10_1186_s12967_025_06524_0 crossref_primary_10_1016_j_fmre_2024_03_014 crossref_primary_10_1016_j_matbio_2023_08_005 crossref_primary_10_1016_j_nano_2023_102691 crossref_primary_10_3390_pharmaceutics12080705 crossref_primary_10_1089_hum_2020_29138_asr crossref_primary_10_1016_j_tcb_2024_03_005 crossref_primary_10_3390_cells9061547 crossref_primary_10_3390_ijms25020838 crossref_primary_10_1016_j_biomaterials_2023_122399 crossref_primary_10_3390_v16071094 crossref_primary_10_1016_j_omtm_2024_101337 crossref_primary_10_1007_s11033_024_09856_0 crossref_primary_10_1089_hum_2020_193 crossref_primary_10_2174_0115665232294935240826061311 crossref_primary_10_1016_j_omtm_2024_101211 crossref_primary_10_1002_adtp_202200128 crossref_primary_10_1016_j_ymthe_2024_09_035 crossref_primary_10_1186_s12872_022_02886_1 crossref_primary_10_3389_fnins_2020_00838 crossref_primary_10_1016_j_bbadis_2024_167055 crossref_primary_10_1016_j_ymthe_2022_05_018 crossref_primary_10_1016_j_cobme_2023_100496 crossref_primary_10_3390_cells10113043 crossref_primary_10_1038_s41589_022_01077_5 crossref_primary_10_1038_s41467_025_60610_x crossref_primary_10_1002_bit_28828 crossref_primary_10_1016_j_ab_2024_115482 crossref_primary_10_1186_s12951_022_01717_x crossref_primary_10_1371_journal_ppat_1009758 crossref_primary_10_1038_s41392_021_00631_2 crossref_primary_10_1177_10430342251376043 crossref_primary_10_3390_pharmaceutics13040586 crossref_primary_10_1016_j_envres_2023_115481 crossref_primary_10_1007_s12033_020_00294_4 crossref_primary_10_1002_dta_2907 crossref_primary_10_1002_jms_4786 crossref_primary_10_1016_j_jconrel_2023_01_067 crossref_primary_10_1039_D1BM00537E crossref_primary_10_1089_hum_2024_124 crossref_primary_10_3390_pharmaceutics13111875 crossref_primary_10_3389_fmicb_2022_1063706 crossref_primary_10_1016_j_omtn_2023_02_014 crossref_primary_10_1007_s10238_024_01463_4 crossref_primary_10_3390_pharmaceutics12121216 crossref_primary_10_1080_14712598_2022_2150543 crossref_primary_10_1016_j_coph_2022_102204 crossref_primary_10_1177_11206721211049001 crossref_primary_10_3892_ijmm_2023_5302 crossref_primary_10_1089_hum_2024_229 crossref_primary_10_1016_j_omtm_2021_06_009 crossref_primary_10_1038_s41598_023_33448_w crossref_primary_10_1038_s41556_020_00598_2 crossref_primary_10_1186_s12951_024_02805_w crossref_primary_10_1016_j_jpeds_2020_05_044 crossref_primary_10_1093_eurheartj_ehaf053 crossref_primary_10_3390_cells11040694 crossref_primary_10_1038_s41467_024_45008_5 crossref_primary_10_3892_etm_2024_12385 crossref_primary_10_1089_hum_2024_233 crossref_primary_10_1038_s41431_021_00811_2 crossref_primary_10_1016_j_omtm_2022_12_014 crossref_primary_10_1002_cac2_12366 crossref_primary_10_3389_fimmu_2024_1423212 crossref_primary_10_1016_j_cej_2023_146857 crossref_primary_10_1016_j_cytogfr_2024_09_003 crossref_primary_10_1038_s41434_022_00371_0 crossref_primary_10_1038_s41408_024_01036_4 crossref_primary_10_3390_vaccines12060636 crossref_primary_10_1002_bit_28967 crossref_primary_10_1007_s00115_022_01287_1 crossref_primary_10_1002_biot_202300667 crossref_primary_10_1038_s44222_024_00235_9 crossref_primary_10_1016_j_jconrel_2024_03_056 crossref_primary_10_1038_s41572_023_00456_z crossref_primary_10_1007_s00439_025_02757_7 crossref_primary_10_1016_j_scib_2023_11_015 crossref_primary_10_1016_j_ymthe_2025_04_045 crossref_primary_10_1111_jns_12543 crossref_primary_10_3390_ijms26178722 crossref_primary_10_1007_s00109_020_02034_2 crossref_primary_10_1099_jgv_0_001960 crossref_primary_10_1016_j_cell_2021_08_028 crossref_primary_10_1016_j_spen_2021_100878 crossref_primary_10_1016_j_biotechadv_2021_107764 crossref_primary_10_1016_j_ymthe_2022_05_014 crossref_primary_10_1089_hum_2019_336 crossref_primary_10_1016_j_isci_2024_110706 crossref_primary_10_1002_mco2_155 crossref_primary_10_1002_asia_202500684 crossref_primary_10_1038_s41467_025_59088_4 crossref_primary_10_1002_adtp_202500127 crossref_primary_10_1111_dmcn_14885 crossref_primary_10_1016_j_virol_2021_08_010 crossref_primary_10_1016_j_xphs_2021_03_024 crossref_primary_10_1186_s12929_025_01123_z crossref_primary_10_3389_fcell_2023_1278968 crossref_primary_10_1111_jcmm_17858 crossref_primary_10_1186_s40364_023_00509_1 crossref_primary_10_3390_biology14091289 crossref_primary_10_1038_s41434_025_00561_6 crossref_primary_10_1016_j_pneurobio_2022_102284 crossref_primary_10_3390_pharmaceutics16121518 crossref_primary_10_1016_j_biomaterials_2023_122403 crossref_primary_10_1016_j_visres_2023_108257 crossref_primary_10_1126_scitranslmed_adf3357 crossref_primary_10_1016_j_drudis_2023_103610 crossref_primary_10_3390_v14071500 crossref_primary_10_1007_s11248_024_00377_x crossref_primary_10_1056_NEJMoa2307798 crossref_primary_10_1134_S0026893325700244 crossref_primary_10_1016_j_biotechadv_2024_108322 crossref_primary_10_1016_j_ymthe_2021_04_005 crossref_primary_10_1038_s41467_024_48974_y crossref_primary_10_3390_cimb46080499 crossref_primary_10_3390_ijms232112715 crossref_primary_10_1016_j_tibtech_2023_08_003 crossref_primary_10_1038_s41467_024_54475_9 crossref_primary_10_1002_smtd_202000309 crossref_primary_10_1177_15357597221120348 crossref_primary_10_1186_s42826_023_00177_0 crossref_primary_10_1002_adtp_202300082 crossref_primary_10_1016_j_ymthe_2024_09_008 crossref_primary_10_1016_j_cbpa_2024_102532 crossref_primary_10_1038_s41434_021_00299_x crossref_primary_10_1038_s41598_023_49112_2 crossref_primary_10_3390_cells12030440 crossref_primary_10_3390_pharmaceutics16040535 crossref_primary_10_3390_v14020266 crossref_primary_10_1016_j_ijcard_2023_131617 crossref_primary_10_3390_biomedicines13020361 crossref_primary_10_1016_j_omton_2025_201040 crossref_primary_10_3389_fimmu_2025_1641289 crossref_primary_10_1172_JCI189075 crossref_primary_10_1016_j_ymthe_2025_03_064 crossref_primary_10_1038_s41398_023_02692_z crossref_primary_10_1080_14728222_2023_2247563 crossref_primary_10_1016_j_pharmthera_2023_108521 crossref_primary_10_1016_j_apsb_2025_05_007 crossref_primary_10_1002_adtp_202500149 crossref_primary_10_1038_s41467_021_23561_7 crossref_primary_10_1371_journal_pone_0308817 crossref_primary_10_1016_j_intimp_2024_113475 crossref_primary_10_1038_s41434_023_00411_3 crossref_primary_10_1002_advs_202402166 crossref_primary_10_1039_D4BM00286E crossref_primary_10_2147_IJN_S459905 crossref_primary_10_1186_s13287_024_03757_6 crossref_primary_10_1073_pnas_2004840117 crossref_primary_10_1039_D4SC03666B crossref_primary_10_1021_jasms_4c00151 crossref_primary_10_1038_s41598_025_86815_0 crossref_primary_10_1016_j_bcp_2025_117332 crossref_primary_10_1038_s41572_022_00380_8 crossref_primary_10_1016_j_ymthe_2024_01_024 crossref_primary_10_1155_2023_8408574 crossref_primary_10_3389_fgeed_2022_899209 crossref_primary_10_1016_j_exer_2024_110223 crossref_primary_10_1038_s41536_022_00233_8 crossref_primary_10_1208_s12249_024_03010_6 crossref_primary_10_1016_j_jddst_2025_106798 crossref_primary_10_1038_s41388_022_02454_z crossref_primary_10_1016_j_chroma_2024_465586 crossref_primary_10_3390_microorganisms11102404 crossref_primary_10_3390_v17101289 crossref_primary_10_1016_j_lfs_2024_123227 crossref_primary_10_1016_j_mocell_2025_100189 crossref_primary_10_1016_j_jconrel_2025_02_015 crossref_primary_10_3389_fnana_2024_1469250 crossref_primary_10_1016_j_omtm_2021_11_011 crossref_primary_10_1038_s41467_024_45383_z crossref_primary_10_1177_10738584211057047 crossref_primary_10_1016_j_omtm_2022_06_009 crossref_primary_10_1208_s12248_021_00678_7 crossref_primary_10_1002_bit_28932 crossref_primary_10_1186_s13619_024_00205_x crossref_primary_10_1016_j_ymthe_2022_06_004 crossref_primary_10_1007_s13402_024_00954_6 crossref_primary_10_1016_j_scib_2023_12_006 crossref_primary_10_1038_s41434_020_0177_1 crossref_primary_10_1002_anie_202107036 crossref_primary_10_1038_s44161_025_00665_7 crossref_primary_10_1016_j_omtn_2023_01_007 crossref_primary_10_1016_j_ymthe_2025_03_041 crossref_primary_10_1016_j_cclet_2025_111213 crossref_primary_10_3390_cells13231973 crossref_primary_10_1038_s41467_023_38327_6 crossref_primary_10_1371_journal_pone_0243359 crossref_primary_10_1080_14728222_2022_2067479 crossref_primary_10_3390_nano12193323 crossref_primary_10_26907_2542_064X_2024_4_683_703 crossref_primary_10_1089_hum_2023_152 crossref_primary_10_1089_hum_2022_119 crossref_primary_10_1038_s41434_024_00471_z crossref_primary_10_3389_fbioe_2022_901317 crossref_primary_10_1002_advs_202410494 crossref_primary_10_3389_fgene_2022_961848 crossref_primary_10_1016_j_omtm_2023_08_021 crossref_primary_10_1055_s_0042_1760292 crossref_primary_10_2217_pmt_2020_0021 crossref_primary_10_1016_j_mattod_2025_06_034 crossref_primary_10_1016_j_neuron_2025_03_023 crossref_primary_10_1038_s41434_021_00296_0 crossref_primary_10_3389_fncel_2025_1577117 crossref_primary_10_3390_ijms22179187 crossref_primary_10_3390_ijms242015230 crossref_primary_10_1093_nar_gkaf422 crossref_primary_10_1016_j_omtm_2021_12_001 crossref_primary_10_1016_j_omtn_2024_102176 crossref_primary_10_1016_j_physrep_2022_02_004 crossref_primary_10_1016_j_omtm_2025_101494 crossref_primary_10_1038_s41587_020_0565_5 crossref_primary_10_3389_fbioe_2023_1147244 crossref_primary_10_1016_j_omtm_2025_101496 crossref_primary_10_1016_j_matdes_2022_110758 crossref_primary_10_1016_j_ymthe_2024_07_016 crossref_primary_10_1002_cbf_3676 crossref_primary_10_1002_ctm2_1607 crossref_primary_10_3389_ti_2025_13971 crossref_primary_10_1038_s41551_025_01379_8 crossref_primary_10_17225_jhp00176 crossref_primary_10_3390_ijms24032676 crossref_primary_10_1016_j_omtm_2020_09_001 crossref_primary_10_1177_1091581820966315 crossref_primary_10_1016_j_xphs_2023_05_009 crossref_primary_10_1172_JCI143780 crossref_primary_10_1038_s41467_022_31745_y crossref_primary_10_1177_10915818231153996 crossref_primary_10_1016_j_omtm_2020_09_009 crossref_primary_10_7554_eLife_64175 crossref_primary_10_3390_biom14091138 crossref_primary_10_1016_j_ymthe_2022_03_004 crossref_primary_10_1111_imr_13149 crossref_primary_10_3390_vaccines13010030 crossref_primary_10_3389_fcimb_2021_820355 crossref_primary_10_1038_s41392_024_01780_w crossref_primary_10_1093_nar_gkad375 crossref_primary_10_3390_v15051054 crossref_primary_10_1021_jacs_3c11914 crossref_primary_10_1038_s41596_025_01243_8 crossref_primary_10_1002_pol_20240970 crossref_primary_10_1089_hum_2023_055 crossref_primary_10_3390_ijms24087481 crossref_primary_10_1038_s41380_023_02018_x crossref_primary_10_1038_s41467_025_62128_8 crossref_primary_10_3390_insects16040424 crossref_primary_10_1016_j_mrrev_2024_108515 crossref_primary_10_1016_j_omtm_2020_09_019 crossref_primary_10_1039_D3NR02175K crossref_primary_10_3390_ijms21176240 crossref_primary_10_1093_cvr_cvaf109 crossref_primary_10_1038_s41596_021_00666_3 crossref_primary_10_3390_ijms26146879 crossref_primary_10_1016_j_omtn_2024_102196 crossref_primary_10_1089_hum_2021_219 crossref_primary_10_1007_s10528_023_10565_9 crossref_primary_10_3390_cells13221849 crossref_primary_10_1016_j_jpba_2024_116452 crossref_primary_10_1016_j_pharmthera_2025_108862 crossref_primary_10_1016_j_hlc_2023_05_006 crossref_primary_10_1038_s41467_024_52002_4 crossref_primary_10_3390_microorganisms9091956 crossref_primary_10_1016_j_heliyon_2024_e39323 crossref_primary_10_1146_annurev_genom_083117_021702 crossref_primary_10_3390_ijms25073630 crossref_primary_10_3389_fimmu_2021_753467 crossref_primary_10_3389_fnins_2024_1287228 crossref_primary_10_3390_vaccines10122035 crossref_primary_10_1016_j_ymthe_2025_08_025 crossref_primary_10_3390_brainsci13101419 crossref_primary_10_1002_btpr_70025 crossref_primary_10_1016_j_trsl_2021_04_009 crossref_primary_10_1186_s43556_022_00095_y crossref_primary_10_1016_j_biotechadv_2024_108433 crossref_primary_10_1007_s11033_024_09521_6 crossref_primary_10_1016_j_ajps_2025_101068 crossref_primary_10_4103_IJO_IJO_2902_23 crossref_primary_10_1002_adma_202414882 crossref_primary_10_1089_neu_2023_0141 crossref_primary_10_1080_13543784_2021_1939674 crossref_primary_10_1093_nar_gkab174 crossref_primary_10_3390_j7030023 crossref_primary_10_1016_j_jconrel_2021_03_029 crossref_primary_10_1111_jcmm_70051 crossref_primary_10_1002_pi_6252 crossref_primary_10_1016_j_ymthe_2023_12_015 crossref_primary_10_1002_elps_202200079 crossref_primary_10_1002_adma_202102219 crossref_primary_10_3233_JND_210662 crossref_primary_10_1016_j_avsg_2024_01_031 crossref_primary_10_3390_v16081215 crossref_primary_10_1016_j_heliyon_2024_e34927 crossref_primary_10_1002_adma_202412430 crossref_primary_10_1089_hum_2024_162 crossref_primary_10_1371_journal_pone_0299402 crossref_primary_10_1038_s41598_023_45376_w crossref_primary_10_1002_advs_202413561 crossref_primary_10_1007_s40259_020_00453_8 crossref_primary_10_1186_s13023_022_02324_7 crossref_primary_10_14348_molcells_2022_0163 crossref_primary_10_3390_pharmaceutics13050750 crossref_primary_10_1016_j_omtm_2021_03_005 crossref_primary_10_1016_j_semcdb_2021_06_019 crossref_primary_10_1007_s00216_024_05623_z crossref_primary_10_3390_ph15010023 crossref_primary_10_1038_s41551_021_00788_9 crossref_primary_10_3390_ijms232214467 crossref_primary_10_1016_j_ajo_2024_12_010 crossref_primary_10_1038_s41573_025_01236_y crossref_primary_10_1016_j_addr_2020_11_002 crossref_primary_10_1016_j_lfs_2021_119142 crossref_primary_10_1016_j_ymthe_2024_08_021 crossref_primary_10_1186_s12951_025_03595_5 crossref_primary_10_1016_j_fmre_2022_08_015 crossref_primary_10_1089_hum_2024_034 crossref_primary_10_1016_j_cell_2022_12_022 crossref_primary_10_1038_s41598_024_66546_4 crossref_primary_10_3390_v13071306 crossref_primary_10_1080_03008207_2025_2520319 crossref_primary_10_1038_s41467_025_63377_3 crossref_primary_10_1371_journal_pone_0261269 crossref_primary_10_1186_s42444_022_00060_4 crossref_primary_10_1038_s41568_023_00593_3 crossref_primary_10_1016_j_copbio_2021_06_025 crossref_primary_10_3389_fimmu_2023_1116084 crossref_primary_10_1016_j_fsi_2025_110280 crossref_primary_10_1016_j_molmed_2024_05_004 crossref_primary_10_1038_s41434_025_00520_1 crossref_primary_10_1146_annurev_genom_022024_125543 crossref_primary_10_1038_s41467_021_26485_4 crossref_primary_10_1038_s44321_025_00209_3 crossref_primary_10_1055_s_0044_1787190 crossref_primary_10_3390_ijms241411347 crossref_primary_10_1186_s12951_023_02285_4 crossref_primary_10_1371_journal_ppat_1012260 crossref_primary_10_31083_j_fbl2810247 crossref_primary_10_3390_v17030333 crossref_primary_10_3390_pharmaceutics14061287 crossref_primary_10_1080_14712598_2022_2060737 crossref_primary_10_1038_s41434_020_0169_1 crossref_primary_10_1186_s13287_021_02401_x crossref_primary_10_3389_fmed_2023_1310050 crossref_primary_10_1016_j_addr_2020_12_011 crossref_primary_10_1016_j_gene_2024_149122 crossref_primary_10_1017_erm_2024_4 crossref_primary_10_1016_j_ymthe_2021_07_011 crossref_primary_10_1089_hum_2023_148 crossref_primary_10_1038_s41569_020_00499_9 crossref_primary_10_1002_advs_202201293 crossref_primary_10_1021_acs_bioconjchem_5c00040 crossref_primary_10_1016_j_chroma_2025_466219 crossref_primary_10_1016_j_omtm_2023_06_010 crossref_primary_10_1016_j_jconrel_2023_12_017 crossref_primary_10_3389_fmolb_2021_624988 crossref_primary_10_1016_j_virol_2021_01_012 crossref_primary_10_1038_s41392_023_01654_7 crossref_primary_10_15252_emmm_202217230 crossref_primary_10_3390_cells14100743 crossref_primary_10_3390_ijms26020816 crossref_primary_10_1038_s41467_022_28738_2 crossref_primary_10_1002_cm_21826 crossref_primary_10_1146_annurev_med_043021_033013 crossref_primary_10_3390_bioengineering10111252 crossref_primary_10_1016_j_ejmech_2024_117010 crossref_primary_10_1089_gen_41_09_16 crossref_primary_10_3390_cells12202494 crossref_primary_10_1002_adhm_202500746 crossref_primary_10_3390_pathophysiology28020016 crossref_primary_10_3390_v15020315 crossref_primary_10_3390_v13071205 crossref_primary_10_1016_j_neurot_2024_e00434 crossref_primary_10_3389_fimmu_2022_1011143 crossref_primary_10_1161_CIRCRESAHA_122_320496 crossref_primary_10_3390_ijms23073465 crossref_primary_10_1016_j_omtn_2024_102143 crossref_primary_10_1016_j_omtn_2024_102264 crossref_primary_10_1089_hum_2022_194 crossref_primary_10_1016_j_omtm_2024_101243 crossref_primary_10_1016_j_pharmthera_2022_108171 crossref_primary_10_3389_fimmu_2021_672449 crossref_primary_10_1016_j_omtm_2024_101360 crossref_primary_10_1002_marc_202300192 crossref_primary_10_1016_j_omtm_2022_04_014 crossref_primary_10_1016_j_intimp_2025_114267 crossref_primary_10_1016_j_omtm_2023_02_009 crossref_primary_10_3390_pharmaceutics13081217 crossref_primary_10_3390_vaccines12020155 crossref_primary_10_3389_fcell_2022_903812 crossref_primary_10_3390_genes13020257 crossref_primary_10_3390_v15091801 crossref_primary_10_3390_v13071336 crossref_primary_10_1002_wnan_1938 crossref_primary_10_1002_biot_202000022 crossref_primary_10_1002_biot_202000025 crossref_primary_10_1016_j_ab_2021_114306 crossref_primary_10_1038_s41596_023_00875_y crossref_primary_10_1016_j_cis_2024_103232 crossref_primary_10_1016_j_ebiom_2023_104453 crossref_primary_10_1016_j_omtm_2025_101520 crossref_primary_10_1016_j_omtm_2021_02_010 crossref_primary_10_1016_j_omtm_2024_101351 crossref_primary_10_1016_j_trsl_2025_09_003 crossref_primary_10_1002_jmv_70447 crossref_primary_10_1038_s41467_024_48221_4 crossref_primary_10_1177_01926233231213851 crossref_primary_10_3389_fcimb_2023_1301915 crossref_primary_10_1016_S0929_693X_23_00227_0 crossref_primary_10_1161_CIRCULATIONAHA_120_050812 crossref_primary_10_1002_pro_4769 crossref_primary_10_3390_cells10102712 crossref_primary_10_3389_fddev_2023_1148795 crossref_primary_10_3389_fimmu_2023_1212136 crossref_primary_10_1016_j_jphs_2025_07_005 crossref_primary_10_3389_fbioe_2023_1275945 crossref_primary_10_1038_s41467_024_52149_0 crossref_primary_10_3390_biomedicines11082227 crossref_primary_10_1089_cell_2023_0072 crossref_primary_10_1016_j_ymben_2024_12_003 crossref_primary_10_1089_hum_2021_046 crossref_primary_10_3390_biology13121052 crossref_primary_10_1055_a_1384_0818 crossref_primary_10_1038_s41434_022_00332_7 crossref_primary_10_1016_j_ymthe_2022_01_010 crossref_primary_10_1089_hum_2021_169 crossref_primary_10_1016_j_omtm_2025_101532 crossref_primary_10_1016_j_addr_2020_12_007 crossref_primary_10_1016_j_chroma_2024_464632 crossref_primary_10_1016_j_molmed_2020_09_010 crossref_primary_10_1016_j_omtm_2024_101234 crossref_primary_10_3390_jcm13237385 crossref_primary_10_1007_s12033_025_01482_w crossref_primary_10_1016_j_braindev_2021_12_006 crossref_primary_10_1016_j_omtm_2020_12_011 crossref_primary_10_1016_j_ymthe_2024_05_032 crossref_primary_10_1128_JVI_00264_21 crossref_primary_10_1016_j_ebiom_2023_104682 crossref_primary_10_1016_j_omtm_2025_101412 crossref_primary_10_1038_s41576_023_00597_7 crossref_primary_10_3390_pathogens11070756 crossref_primary_10_1016_j_omtm_2025_101420 crossref_primary_10_1126_science_abg2822 crossref_primary_10_1016_j_omtn_2025_102635 crossref_primary_10_1038_s41571_024_00883_1 crossref_primary_10_3390_molecules28227679 crossref_primary_10_1016_j_omtm_2020_08_006 crossref_primary_10_1002_advs_202407373 crossref_primary_10_1016_j_bbrc_2023_10_004 crossref_primary_10_1080_14740338_2024_2447072 crossref_primary_10_1186_s13059_024_03257_z crossref_primary_10_3389_fneur_2022_1051559 crossref_primary_10_1016_j_actbio_2024_07_023 crossref_primary_10_1007_s40259_023_00585_7 crossref_primary_10_1089_hum_2021_055 crossref_primary_10_1016_j_omtm_2025_101426 crossref_primary_10_1038_s41434_023_00383_4 crossref_primary_10_1172_JCI159179 crossref_primary_10_1002_biot_202400529 crossref_primary_10_1016_j_omtn_2024_102344 crossref_primary_10_1002_med_22036 crossref_primary_10_1038_s41467_024_50095_5 crossref_primary_10_1002_bit_28296 crossref_primary_10_1016_j_apsb_2021_05_020 crossref_primary_10_1007_s00216_025_05874_4 crossref_primary_10_3390_biomedicines11102725 crossref_primary_10_1016_j_biomaterials_2023_122088 crossref_primary_10_1016_j_ymthe_2024_10_017 crossref_primary_10_1111_cns_14392 crossref_primary_10_3390_microorganisms12020384 crossref_primary_10_1002_adhm_202001046 crossref_primary_10_1016_j_hoc_2022_04_002 crossref_primary_10_4103_1673_5374_314309 crossref_primary_10_1186_s12951_023_02147_z crossref_primary_10_1016_j_cej_2022_140962 crossref_primary_10_1016_j_xphs_2025_103891 crossref_primary_10_1038_s41598_021_01220_7 crossref_primary_10_15252_emmm_201809824 crossref_primary_10_1016_j_omtm_2024_101377 crossref_primary_10_1080_14712598_2021_1865304 crossref_primary_10_1016_j_chroma_2024_464851 crossref_primary_10_1016_j_omtm_2024_101378 crossref_primary_10_1080_14712598_2021_1865303 crossref_primary_10_1242_dmm_050088 crossref_primary_10_1371_journal_ppat_1013533 crossref_primary_10_1007_s12035_021_02555_y crossref_primary_10_1016_j_ymthe_2023_10_002 crossref_primary_10_3389_fimmu_2021_673699 crossref_primary_10_1007_s12264_023_01067_0 crossref_primary_10_1038_s43856_022_00212_6 crossref_primary_10_1016_j_jcyt_2022_07_005 crossref_primary_10_1016_j_ymthe_2025_06_026 crossref_primary_10_1038_s41467_023_42546_2 crossref_primary_10_1007_s11901_023_00624_5 crossref_primary_10_1038_s41467_022_35097_5 crossref_primary_10_1055_s_0041_1722862 crossref_primary_10_1016_j_rpth_2024_102640 crossref_primary_10_1002_ange_202107036 crossref_primary_10_3389_fmicb_2022_953218 crossref_primary_10_1002_jpn3_12326 crossref_primary_10_1007_s12033_025_01381_0 crossref_primary_10_1016_j_jgg_2023_08_001 crossref_primary_10_1136_jnnp_2019_322327 crossref_primary_10_3390_ijms22179380 crossref_primary_10_1016_j_omtn_2023_05_014 crossref_primary_10_1038_s41434_022_00342_5 crossref_primary_10_3389_fimmu_2021_734304 crossref_primary_10_1016_j_mcp_2024_101981 crossref_primary_10_3390_ijms26189162 crossref_primary_10_3390_membranes13090770 crossref_primary_10_1016_j_lfs_2022_120375 crossref_primary_10_1038_s41573_023_00829_9 crossref_primary_10_2217_nnm_2020_0078 crossref_primary_10_3390_pharmaceutics12080767 crossref_primary_10_3389_fgeed_2022_1037290 crossref_primary_10_3390_cells11121881 crossref_primary_10_1016_j_ijpharm_2024_123985 crossref_primary_10_3390_pharmaceutics14102129 crossref_primary_10_1016_j_omtm_2023_03_010 crossref_primary_10_3390_jpm12121979 crossref_primary_10_3389_fimmu_2025_1513546 crossref_primary_10_1089_hum_2021_123 crossref_primary_10_1093_cvr_cvaa107 crossref_primary_10_1089_hum_2021_124 crossref_primary_10_1016_j_omtn_2023_05_007 crossref_primary_10_1186_s13045_022_01224_4 crossref_primary_10_1021_acsomega_5c01294 crossref_primary_10_1007_s40291_023_00687_6 crossref_primary_10_1016_j_pharmthera_2024_108596 crossref_primary_10_1016_j_neurot_2024_e00391 crossref_primary_10_3390_pharmaceutics13060810 crossref_primary_10_1002_mco2_70030 crossref_primary_10_1016_j_ymthe_2025_07_007 crossref_primary_10_1161_ATVBAHA_122_318902 crossref_primary_10_3390_cimb47040268 crossref_primary_10_1021_jacs_4c13393 crossref_primary_10_1089_hum_2022_178 crossref_primary_10_3390_ctn9030032 crossref_primary_10_3233_JPD_212674 crossref_primary_10_3389_fimmu_2021_701636 crossref_primary_10_1002_jcph_2141 crossref_primary_10_1155_2024_5487973 crossref_primary_10_3389_fgene_2021_794805 crossref_primary_10_1002_cam4_7375 crossref_primary_10_1186_s12964_025_02246_4 crossref_primary_10_4103_1673_5374_297060 crossref_primary_10_1002_mco2_645 crossref_primary_10_1016_j_cobme_2021_100353 crossref_primary_10_1167_iovs_66_1_6 crossref_primary_10_1089_hum_2021_136 crossref_primary_10_1186_s12885_023_11705_5 crossref_primary_10_3390_v16111760 crossref_primary_10_1089_hum_2022_181 crossref_primary_10_1002_ana_26656 crossref_primary_10_1016_j_omtm_2024_101298 crossref_primary_10_1002_bit_28495 crossref_primary_10_1172_JCI145700 crossref_primary_10_1016_j_omtm_2024_101293 crossref_primary_10_3390_cells12050732 crossref_primary_10_1073_pnas_2121273119 crossref_primary_10_1089_hum_2020_118 crossref_primary_10_1089_hum_2022_189 crossref_primary_10_1007_s13205_025_04366_7 crossref_primary_10_1016_j_virusres_2023_199191 crossref_primary_10_1002_adhm_202401577 crossref_primary_10_3390_pharmaceutics13020159 crossref_primary_10_1016_j_omtm_2021_09_006 crossref_primary_10_1186_s12985_021_01555_7 crossref_primary_10_26599_NR_2025_94907516 crossref_primary_10_3390_genes14122162 crossref_primary_10_1016_j_bioactmat_2022_03_042 crossref_primary_10_1038_s41434_023_00409_x |
| Cites_doi | 10.1056/NEJMoa1407309 10.1016/j.clim.2017.07.006 10.1038/mt.2011.119 10.1016/j.ymthe.2017.09.021 10.1146/annurev-virology-092818-015530 10.1038/nn.4593 10.1007/978-1-4939-3271-9_2 10.1073/pnas.0802866105 10.1016/j.omtm.2018.08.001 10.1016/j.gendis.2017.04.001 10.4049/jimmunol.0803965 10.1056/NEJMoa1412965 10.1038/sj.mt.6300322 10.1126/scitranslmed.3005708 10.1038/mt.2015.179 10.1007/s11095-018-2554-7 10.1128/JVI.00297-12 10.1126/scitranslmed.3003454 10.1038/gt.2016.75 10.1089/hum.2017.218 10.1167/iovs.16-19087 10.1128/JVI.01813-13 10.1016/S0140-6736(16)00082-9 10.1016/j.coph.2015.08.002 10.1073/pnas.86.20.8078 10.1038/nbt.2643 10.1016/j.omtm.2018.02.003 10.1038/mt.2010.170 10.1038/mt.2015.174 10.1038/nbt.3781 10.1016/j.neulet.2017.11.049 10.1038/nbt.3801 10.1089/hum.2017.150 10.1016/j.omtm.2018.09.005 10.15252/emmm.201707573 10.1016/j.ymthe.2017.09.006 10.1038/nm1358 10.1089/hum.2016.128 10.1016/j.jmb.2018.05.022 10.1056/NEJMoa1000228 10.1056/NEJMoa1108046 10.1016/j.ymthe.2018.07.011 10.1146/annurev-bioeng-071813-104938 10.1371/journal.ppat.1006929 10.1089/hum.2013.065 10.1016/j.biomaterials.2018.05.041 10.1016/j.ymthe.2017.03.029 10.1038/nrd.2018.110 10.1182/blood-2005-10-4035 10.1038/mt.2014.178 10.1016/j.immuni.2019.02.005 10.1093/hmg/ddu028 10.1089/hum.2013.164 10.1038/nrg3742 10.1038/mt.2011.157 10.1016/S1074-7613(00)80349-0 10.1089/hgtb.2012.195 10.1016/j.cell.2016.06.049 10.1038/nbt856 10.1038/mt.2015.134 10.1056/NEJMoa1706198 10.1089/hum.1998.9.18-2745 10.1038/mt.2014.114 10.1038/nbt.3440 10.1038/mtm.2015.40 10.1172/JCI68205 10.1080/14712598.2018.1479739 10.1038/mt.2012.194 10.1038/mt.2008.269 10.1172/jci.insight.120474 10.1074/jbc.M113.482380 10.1016/j.omtm.2017.12.004 10.1002/emmm.201202291 10.1073/pnas.162250899 10.1038/mt.2015.206 10.1038/nbt0817-691 10.1089/hum.2006.139 10.1128/JVI.02710-14 10.1186/s12967-017-1200-1 10.1038/mt.2015.187 10.1016/j.omtm.2019.05.012 10.1126/scitranslmed.3005795 10.1128/JVI.78.9.4421-4432.2004 10.1080/14712598.2017.1356817 10.1038/sj.gt.3302134 10.3390/diseases6020042 10.1172/jci.insight.99052 10.1089/hum.2013.184 10.1016/j.omtm.2018.01.002 10.1089/hum.2017.016 10.1038/260805a0 10.1016/j.jconrel.2017.08.005 10.1128/JVI.01990-07 10.1182/blood-2018-04-839217 10.1038/sj.gt.3300938 10.1128/JVI.02953-15 10.1016/j.omtm.2018.07.011 10.1038/s41591-018-0209-1 10.1016/j.jviromet.2006.11.019 10.1006/jmbi.1996.0428 10.1182/blood-2012-10-460733 10.15252/emmm.201506078 10.1038/mt.2014.139 10.1126/science.aan4672 10.1056/NEJMoa1709866 10.1089/hum.2015.001 10.1038/s41434-018-0034-7 10.1128/JVI.74.18.8732-8739.2000 10.1038/nrd.2018.158 10.1016/j.virol.2018.02.007 10.1089/hgtb.2012.243 10.1089/hum.2008.161 10.1089/hum.2017.042 10.1161/CIRCRESAHA.118.311587 10.1093/hmg/ddx427 10.1038/s41434-019-0104-5 10.1016/j.ymthe.2003.08.021 10.1182/blood-2018-07-820720 10.1080/14712598.2018.1389886 10.1016/j.ymthe.2006.05.009 10.1172/JCI37607 10.1016/S2352-4642(17)30125-6 10.1016/j.jhep.2016.05.012 10.1016/j.omtm.2018.03.004 10.1002/jgm.967 10.1038/s41576-018-0051-9 10.1073/pnas.0902269106 10.1089/hum.2015.025 10.1371/journal.pgen.0020221 10.1182/blood-2017-09-804419 10.1038/mt.2016.62 10.1074/jbc.M115.687657 10.1128/JVI.03443-12 10.1002/j.1460-2075.1996.tb00689.x 10.1016/j.ymthe.2017.08.018 10.1089/hgtb.2016.054 10.1038/gt.2015.74 10.1128/JVI.01826-13 10.3389/fimmu.2018.00844 10.1038/mt.2009.128 10.1073/pnas.1704766114 10.1056/NEJMoa1708483 10.1016/j.ymthe.2006.02.014 10.1016/j.omtm.2017.11.002 10.1006/mthe.2001.0462 10.1182/blood-2010-10-314518 10.1128/JVI.79.9.5296-5303.2005 10.1016/j.omtm.2018.01.004 10.1089/hum.2017.220 10.1146/annurev-pathol-052016-100332 10.1016/j.celrep.2015.07.019 10.1016/j.jconrel.2018.08.018 10.1038/nbt1182 10.1172/JCI66611 10.1056/NEJMoa1708538 10.1038/sj.mt.6300355 10.1038/mt.2013.184 10.1142/S1568558610000197 10.1128/JVI.00675-12 10.1038/mt.2010.172 10.1038/gt.2011.143 10.1038/nrg2971 10.1128/JVI.01536-06 10.1038/nature12875 10.1128/JVI.79.4.2528-2540.2005 10.1038/mt.2011.22 10.1016/j.virol.2012.05.004 10.1016/j.ymthe.2017.08.003 10.1016/j.coviro.2017.06.003 10.1038/mt.2011.237 10.1006/mthe.2001.0345 10.1126/scitranslmed.aav4523 10.1093/hmg/ddr141 10.1016/j.omtm.2019.01.003 10.1016/j.hlc.2018.03.005 10.1161/01.CIR.0000109697.68832.5D 10.1056/NEJMoa1414221 10.1038/mtm.2013.12 10.1016/j.ymthe.2018.01.018 10.1128/JVI.00710-17 10.1038/mt.2016.61 10.1006/mthe.2001.0456 10.1002/btm2.10090 10.1073/pnas.1218933110 10.1128/JVI.00254-08 10.1128/JVI.01394-18 |
| ContentType | Journal Article |
| Copyright | Springer Nature Limited 2020 COPYRIGHT 2020 Nature Publishing Group 2020© Springer Nature Limited 2020 Springer Nature Limited 2020. |
| Copyright_xml | – notice: Springer Nature Limited 2020 – notice: COPYRIGHT 2020 Nature Publishing Group – notice: 2020© Springer Nature Limited 2020 – notice: Springer Nature Limited 2020. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM ISR 3V. 7QP 7QR 7RV 7TK 7TM 7X7 7XB 88A 88E 8AO 8C1 8FD 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ HCIFZ K9. KB0 LK8 M0S M1P M7P NAPCQ P64 PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS RC3 7X8 |
| DOI | 10.1038/s41576-019-0205-4 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Gale In Context: Science ProQuest Central (Corporate) Calcium & Calcified Tissue Abstracts Chemoreception Abstracts Nursing & Allied Health Database Neurosciences Abstracts Nucleic Acids Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database Technology Research Database ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni Edition) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) ProQuest Biological Science Collection Health & Medical Collection (Alumni Edition) Medical Database Biological Science Database Nursing & Allied Health Premium Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China Genetics Abstracts MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Central Student Technology Research Database ProQuest One Academic Middle East (New) ProQuest Central Essentials Nucleic Acids Abstracts ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central China ProQuest Biology Journals (Alumni Edition) ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Genetics Abstracts Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection Chemoreception Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Public Health ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection Neurosciences Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | ProQuest Central Student MEDLINE ProQuest Central Student MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Agriculture Biology |
| EISSN | 1471-0064 |
| EndPage | 272 |
| ExternalDocumentID | A618257180 32042148 10_1038_s41576_019_0205_4 |
| Genre | Journal Article Review Research Support, N.I.H., Extramural |
| GeographicLocations | United States |
| GeographicLocations_xml | – name: United States |
| GrantInformation_xml | – fundername: NHLBI NIH HHS grantid: P01 HL112761 – fundername: NIAID NIH HHS grantid: R01 AI117408 – fundername: NIAID NIH HHS grantid: R01 AI072176 |
| GroupedDBID | --- -DZ .55 0R~ 123 29M 36B 39C 3V. 4.4 53G 70F 7RV 7X7 88A 88E 8AO 8C1 8FE 8FH 8FI 8FJ 8R4 8R5 AAEEF AARCD AAWYQ AAYZH AAZLF ABAWZ ABDBF ABJNI ABLJU ABUWG ACGFS ACIWK ACPRK ACUHS ADBBV AENEX AFBBN AFFNX AFKRA AFSHS AGAYW AGHTU AHBCP AHMBA AHOSX AHSBF AIBTJ ALFFA ALIPV ALMA_UNASSIGNED_HOLDINGS ARMCB ASPBG AVWKF AXYYD AZFZN B0M BBNVY BENPR BHPHI BKEYQ BKKNO BPHCQ BVXVI CCPQU CS3 DB5 DU5 EAD EAP EBS EE. EJD EMB EMK EMOBN EPL ESX EX3 EXGXG F5P FEDTE FQGFK FSGXE FYUFA HCIFZ HMCUK HVGLF HZ~ IAO IGS IHR IHW INH INR ISR ITC LK8 M0L M1P M7P N9A NAPCQ NNMJJ O9- ODYON PQQKQ PROAC PSQYO Q2X RIG RNR RNS RNT RNTTT SHXYY SIXXV SNYQT SOJ SV3 TAOOD TBHMF TDRGL TSG TUS UKHRP WOW X7M ~8M AAYXX ABFSG ACSTC AEZWR AFANA AFHIU AGSTI AHWEU AIXLP ALPWD ATHPR CITATION CGR CUY CVF ECM EIF NPM PHGZM PHGZT 7QP 7QR 7TK 7TM 7XB 8FD 8FK AZQEC DWQXO FR3 GNUQQ K9. P64 PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS RC3 7X8 |
| ID | FETCH-LOGICAL-c598t-ac13eeb4767d8adf94f71b9c8411fa24871be8753c58e1387c4d457c77d6132c3 |
| IEDL.DBID | M7P |
| ISICitedReferencesCount | 868 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000512525800001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1471-0056 1471-0064 |
| IngestDate | Sun Nov 09 11:21:42 EST 2025 Mon Oct 06 18:18:42 EDT 2025 Tue Oct 07 05:13:34 EDT 2025 Sat Nov 29 13:27:01 EST 2025 Sat Nov 29 10:10:09 EST 2025 Wed Nov 26 10:02:27 EST 2025 Thu May 22 21:22:25 EDT 2025 Wed Feb 19 02:30:02 EST 2025 Sat Nov 29 02:34:58 EST 2025 Tue Nov 18 22:36:41 EST 2025 Fri Feb 21 02:40:13 EST 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 4 |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c598t-ac13eeb4767d8adf94f71b9c8411fa24871be8753c58e1387c4d457c77d6132c3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 |
| PMID | 32042148 |
| PQID | 2379540166 |
| PQPubID | 44267 |
| PageCount | 18 |
| ParticipantIDs | proquest_miscellaneous_2353581809 proquest_journals_2474986344 proquest_journals_2379540166 gale_infotracmisc_A618257180 gale_infotracacademiconefile_A618257180 gale_incontextgauss_ISR_A618257180 gale_healthsolutions_A618257180 pubmed_primary_32042148 crossref_primary_10_1038_s41576_019_0205_4 crossref_citationtrail_10_1038_s41576_019_0205_4 springer_journals_10_1038_s41576_019_0205_4 |
| PublicationCentury | 2000 |
| PublicationDate | 2020-04-01 |
| PublicationDateYYYYMMDD | 2020-04-01 |
| PublicationDate_xml | – month: 04 year: 2020 text: 2020-04-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | Nature reviews. Genetics |
| PublicationTitleAbbrev | Nat Rev Genet |
| PublicationTitleAlternate | Nat Rev Genet |
| PublicationYear | 2020 |
| Publisher | Nature Publishing Group UK Nature Publishing Group |
| Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group |
| References | Wang, Cheng, Engelhardt, Yan, Qiu (CR141) 2018; 11 Dunbar (CR4) 2018; 359 Gonzalez-Cordero (CR166) 2013; 31 Lowenstein, Castro (CR186) 2018; 189 Xie (CR15) 2002; 99 Li (CR101) 2009; 106 Mingozzi (CR151) 2013; 5 Monahan (CR84) 2010; 18 Mitchell, Li, Samulski (CR86) 2013; 87 Haberman, McCown, Samulski (CR22) 2000; 74 Villiger (CR54) 2018; 24 Sen (CR130) 2013; 24 Penaud-Budloo, Francois, Clement, Ayuso (CR135) 2018; 8 Korbelin (CR67) 2016; 24 Lundstrom (CR6) 2018; 6 Yan (CR39) 2015; 26 Srivastava, Samulski, Lu, Larsen, Srivastava (CR53) 1989; 86 Zaiss (CR168) 2008; 82 Denard (CR92) 2013; 87 Smith, Levy, Kotin (CR146) 2009; 17 Aiuti, Roncarolo, Naldini (CR10) 2017; 9 Hoggatt (CR187) 2016; 166 Rincon (CR41) 2015; 23 Miesbach (CR174) 2018; 131 Mendell (CR37) 2017; 377 White (CR63) 2004; 109 Nathwani (CR28) 2011; 365 Zhong (CR59) 2008; 105 Moore, Bracha, Hussain, Morral, Ciulla (CR1) 2017; 17 Deverman, Ravina, Bankiewicz, Paul, Sah (CR34) 2018; 17 Buning (CR8) 2013; 5 Wang (CR159) 2015; 23 Deverman, Ravina, Bankiewicz, Paul, Sah (CR175) 2018; 17 Tseng (CR119) 2015; 89 Smith, Agbandje-McKenna (CR122) 2018; 14 Mays (CR110) 2009; 182 Bainbridge (CR170) 2015; 372 Ling, Li, Ma, Srivastava (CR62) 2016; 27 Waterkamp, Muller, Ying, Trepel, Kleinschmidt (CR124) 2006; 8 Varadi (CR68) 2012; 19 Chan (CR76) 2017; 20 Sack, Herzog (CR104) 2009; 11 Rodrigues (CR26) 2018; 36 Nathwani (CR27) 2014; 371 Nicolson, Li, Hirsch, Setola, Samulski (CR87) 2016; 90 Chai (CR95) 2018; 286 Grimm, Kern, Rittner, Kleinschmidt (CR145) 1998; 9 Duan, Yue, Engelhardt (CR47) 2001; 4 Reichel (CR115) 2017; 25 Maddalena (CR89) 2018; 29 Muller (CR66) 2003; 21 Bevan (CR98) 2011; 19 He (CR32) 2013; 24 Maheshri, Koerber, Kaspar, Schaffer (CR70) 2006; 24 Maude (CR11) 2018; 378 Li (CR120) 2012; 86 Vercauteren (CR160) 2016; 24 Rangarajan (CR30) 2017; 377 Markusic (CR61) 2010; 18 McCarty (CR35) 2003; 10 Vandamme, Adjali, Mingozzi (CR117) 2017; 28 Li (CR158) 2015; 23 Denard (CR96) 2018; 10 Liu (CR99) 2014; 1 Cideciyan (CR172) 2013; 110 Zhu, Huang, Yang (CR111) 2009; 119 Nathwani (CR31) 2006; 107 Ojala (CR73) 2018; 26 Petrs-Silva (CR60) 2009; 17 Koerber, Jang, Yu, Kane, Schaffer (CR148) 2007; 18 Bass-Stringer (CR3) 2018; 27 Dittmar, Goodenbour, Pan (CR44) 2006; 2 Pan (CR81) 2017; 35 Wang (CR149) 2015; 2 Wu (CR23) 2008; 16 Li (CR128) 2013; 123 Qu (CR150) 2007; 140 Mitchell, Samulski (CR85) 2013; 87 Bowles (CR46) 2012; 20 Walsh (CR164) 2017; 12 Fitzpatrick (CR97) 2018; 9 Wang (CR142) 2017 Hordeaux (CR154) 2018; 26 Hastie, Samulski (CR14) 2015; 26 Adachi, Nakai (CR65) 2010; 5 Ghosh, Yue, Lai, Duan (CR51) 2008; 16 Mueller (CR182) 2017; 25 Manno (CR29) 2006; 12 Pei (CR94) 2018; 518 Zhang (CR163) 2014; 23 Moore, Morral, Ciulla, Bracha (CR169) 2018; 18 Hirsch (CR50) 2013; 21 Wang (CR93) 2017; 24 Pei (CR129) 2018; 9 George (CR25) 2017; 377 Korbelin (CR69) 2016; 8 Zhang, He, Chai, Samulski, Li (CR100) 2018; 176 Ahn (CR105) 1997; 6 McCraw, O'Donnell, Taylor, Stagg, Chapman (CR118) 2012; 431 Arnold, Sasser, Stachler, Bartlett (CR147) 2006; 14 Nass (CR152) 2018; 9 Kay (CR162) 2015; 23 D'Avola (CR183) 2016; 65 Dalkara (CR77) 2013; 5 Chandler (CR90) 2019; 14 Greenberg (CR181) 2016; 387 Keeler, Flotte (CR12) 2019; 6 Shao (CR161) 2019; 26 Tse (CR123) 2017; 114 Sheridan (CR188) 2017; 35 Shao, Chen, Samulski, Hirsch, Li (CR107) 2018; 27 Chuah (CR40) 2014; 22 Chow, Shadman, Gopal (CR189) 2018; 132 Lee (CR184) 2017; 4 Kondratov (CR138) 2017; 25 Auricchio, O'Connor, Hildinger, Wilson (CR144) 2001; 4 Marsic (CR74) 2014; 22 Chien (CR176) 2017; 1 Wang (CR140) 2017; 7 Kotterman, Schaffer (CR18) 2014; 15 Louis Jeune, Joergensen, Hajjar, Weber (CR116) 2013; 24 Bleker, Sonntag, Kleinschmidt (CR20) 2005; 79 Hirsch, Wolf, Samulski (CR48) 2016; 1382 Rabinowitz (CR82) 2004; 78 Mietzsch (CR137) 2014; 25 Pillay, Carette (CR19) 2017; 24 Wang (CR58) 2018; 9 Grimm (CR125) 2008; 82 Bosma (CR139) 2018; 25 Markusic (CR155) 2017; 15 Greig (CR38) 2017; 28 Grifman (CR64) 2001; 3 Zolotukhin (CR143) 1999; 6 Landegger (CR80) 2017; 35 Koo, Popplewell, Athanasopoulos, Dickson (CR49) 2014; 25 CR121 Li (CR126) 2016; 24 Matsuzaki (CR153) 2018; 665 Xiao (CR108) 2019; 4 Martino (CR112) 2011; 117 Fu (CR36) 2003; 8 Kronenberg, Bottcher, von der Lieth, Bleker, Kleinschmidt (CR21) 2005; 79 Kotin, Snyder (CR136) 2017; 28 Brown (CR45) 2018; 9 Zhang (CR185) 2018; 29 Chan (CR114) 2018; 26 Leone (CR177) 2012; 4 Herrmann, Grimm (CR56) 2018; 430 Shao (CR33) 2018; 3 Santiago-Ortiz (CR78) 2015; 22 Sun (CR102) 2018; 10 Pulicherla (CR71) 2011; 19 Martinez-Navio (CR2) 2019; 50 Shen (CR57) 2013; 288 Kay (CR7) 2011; 12 Dong, Nilsson, Kurland (CR43) 1996; 260 Kotterman, Chalberg, Schaffer (CR5) 2015; 17 Berry, Asokan (CR88) 2016; 291 Ishikawa, Weber, Hajjar (CR180) 2018; 123 Rossi, Manfrin, Lutolf (CR165) 2018; 19 Perrin, Herzog, Markusic (CR173) 2019; 133 Voigt, Martinez, Wang, Mayo, Arnold (CR72) 2002; 9 Yla-Herttuala (CR9) 2012; 20 Denard (CR91) 2012; 86 Cooper (CR109) 2009; 20 Ahn (CR106) 1996; 15 Jacobson (CR171) 2015; 372 Deverman (CR75) 2016; 34 Fakhiri (CR52) 2019; 12 Grieger, Soltys, Samulski (CR134) 2016; 24 Buning, Huber, Zhang, Meumann, Hacker (CR17) 2015; 24 Kaemmerer (CR132) 2018; 3 Aguti, Malerba, Zhou (CR179) 2018; 18 Zinn (CR79) 2015; 12 Faust (CR113) 2013; 123 Sun, Hua, Chen, Samulski, Li (CR103) 2017; 28 Duan, Systemic (CR178) 2018; 26 Garel (CR42) 1976; 260 Nietupski (CR156) 2011; 19 Kotin (CR133) 2011; 20 Chai (CR83) 2017; 262 Wu, Asokan, Samulski (CR13) 2006; 14 Mendell (CR24) 2010; 363 Martino (CR131) 2013; 121 Santos-Ferreira (CR167) 2016; 57 Govindasamy (CR16) 2006; 80 Paulk (CR127) 2018; 26 Tornabene (CR55) 2019; 11 Lisowski (CR157) 2014; 506 J Sun (205_CR102) 2018; 10 K Ahn (205_CR106) 1996; 15 J Garel (205_CR42) 1976; 260 MY Rincon (205_CR41) 2015; 23 AK Herrmann (205_CR56) 2018; 430 AK Zaiss (205_CR168) 2008; 82 J Denard (205_CR92) 2013; 87 RH Smith (205_CR146) 2009; 17 D Dalkara (205_CR77) 2013; 5 DM McCarty (205_CR35) 2003; 10 JB Nietupski (205_CR156) 2011; 19 LV Tse (205_CR123) 2017; 114 B Bosma (205_CR139) 2018; 25 SA Nass (205_CR152) 2018; 9 RP Haberman (205_CR22) 2000; 74 H Dong (205_CR43) 1996; 260 V Louis Jeune (205_CR116) 2013; 24 CS Manno (205_CR29) 2006; 12 K Ahn (205_CR105) 1997; 6 MA Kay (205_CR162) 2015; 23 D Grimm (205_CR145) 1998; 9 MA Kotterman (205_CR18) 2014; 15 E Hastie (205_CR14) 2015; 26 J Zhu (205_CR111) 2009; 119 C Mueller (205_CR182) 2017; 25 L Zhong (205_CR59) 2008; 105 C Li (205_CR120) 2012; 86 AC Nathwani (205_CR31) 2006; 107 C Li (205_CR101) 2009; 106 CA Voigt (205_CR72) 2002; 9 NC Walsh (205_CR164) 2017; 12 T Santos-Ferreira (205_CR167) 2016; 57 J Denard (205_CR96) 2018; 10 Z Yan (205_CR39) 2015; 26 GE Berry (205_CR88) 2016; 291 SM Faust (205_CR113) 2013; 123 Z Chai (205_CR95) 2018; 286 N Pulicherla (205_CR71) 2011; 19 LC Chandler (205_CR90) 2019; 14 G Qu (205_CR150) 2007; 140 S Aguti (205_CR179) 2018; 18 S Bass-Stringer (205_CR3) 2018; 27 D Grimm (205_CR125) 2008; 82 K Adachi (205_CR65) 2010; 5 AM Mitchell (205_CR86) 2013; 87 Y He (205_CR32) 2013; 24 JA Greig (205_CR38) 2017; 28 D Wang (205_CR58) 2018; 9 N Maheshri (205_CR70) 2006; 24 JK Smith (205_CR122) 2018; 14 GA Rodrigues (205_CR26) 2018; 36 DM Markusic (205_CR61) 2010; 18 Q Wang (205_CR149) 2015; 2 OJ Muller (205_CR66) 2003; 21 L Villiger (205_CR54) 2018; 24 JW Bainbridge (205_CR170) 2015; 372 YH Chien (205_CR176) 2017; 1 D Marsic (205_CR74) 2014; 22 ML Hirsch (205_CR50) 2013; 21 A Maddalena (205_CR89) 2018; 29 P Leone (205_CR177) 2012; 4 A Auricchio (205_CR144) 2001; 4 J Hordeaux (205_CR154) 2018; 26 G Rossi (205_CR165) 2018; 19 JC Grieger (205_CR134) 2016; 24 LE Mays (205_CR110) 2009; 182 RM Kotin (205_CR133) 2011; 20 S Rangarajan (205_CR30) 2017; 377 HC Brown (205_CR45) 2018; 9 LD Landegger (205_CR80) 2017; 35 Y Zhang (205_CR163) 2014; 23 A Aiuti (205_CR10) 2017; 9 DM Markusic (205_CR155) 2017; 15 AV Cideciyan (205_CR172) 2013; 110 F Mingozzi (205_CR151) 2013; 5 VA Chow (205_CR189) 2018; 132 Z Wu (205_CR13) 2006; 14 SJ White (205_CR63) 2004; 109 Z Wang (205_CR142) 2017 SC Nicolson (205_CR87) 2016; 90 X Pei (205_CR129) 2018; 9 Q Xie (205_CR15) 2002; 99 T Koo (205_CR49) 2014; 25 D Duan (205_CR178) 2018; 26 KA Dittmar (205_CR44) 2006; 2 W Shao (205_CR33) 2018; 3 Z Chai (205_CR83) 2017; 262 K Vercauteren (205_CR160) 2016; 24 J Sun (205_CR103) 2017; 28 K Varadi (205_CR68) 2012; 19 H Buning (205_CR8) 2013; 5 W Shao (205_CR107) 2018; 27 X Zhang (205_CR100) 2018; 176 GS Arnold (205_CR147) 2006; 14 H Fu (205_CR36) 2003; 8 Y Liu (205_CR99) 2014; 1 H Buning (205_CR17) 2015; 24 M Mietzsch (205_CR137) 2014; 25 W Shao (205_CR161) 2019; 26 X Pei (205_CR94) 2018; 518 FF Reichel (205_CR115) 2017; 25 S Bleker (205_CR20) 2005; 79 KY Chan (205_CR76) 2017; 20 D Sen (205_CR130) 2013; 24 B Pan (205_CR81) 2017; 35 PR Lowenstein (205_CR186) 2018; 189 S Pillay (205_CR19) 2017; 24 CS Lee (205_CR184) 2017; 4 SG Jacobson (205_CR171) 2015; 372 NA Moore (205_CR169) 2018; 18 BK Sack (205_CR104) 2009; 11 C Ling (205_CR62) 2016; 27 DE Bowles (205_CR46) 2012; 20 DM McCraw (205_CR118) 2012; 431 Q Wang (205_CR140) 2017; 7 NK Paulk (205_CR127) 2018; 26 DS Ojala (205_CR73) 2018; 26 MK Chuah (205_CR40) 2014; 22 C Sheridan (205_CR188) 2017; 35 M Wang (205_CR93) 2017; 24 M Grifman (205_CR64) 2001; 3 J Hoggatt (205_CR187) 2016; 166 A Ghosh (205_CR51) 2008; 16 JM Martinez-Navio (205_CR2) 2019; 50 S Yla-Herttuala (205_CR9) 2012; 20 M Cooper (205_CR109) 2009; 20 S Shen (205_CR57) 2013; 288 C Vandamme (205_CR117) 2017; 28 L Lisowski (205_CR157) 2014; 506 MA Kotterman (205_CR5) 2015; 17 H Petrs-Silva (205_CR60) 2009; 17 AT Martino (205_CR112) 2011; 117 Z Wang (205_CR141) 2018; 11 M Penaud-Budloo (205_CR135) 2018; 8 C Li (205_CR128) 2013; 123 WF Kaemmerer (205_CR132) 2018; 3 Z Fitzpatrick (205_CR97) 2018; 9 A Gonzalez-Cordero (205_CR166) 2013; 31 JR Mendell (205_CR24) 2010; 363 J Santiago-Ortiz (205_CR78) 2015; 22 YK Chan (205_CR114) 2018; 26 ML Hirsch (205_CR48) 2016; 1382 JR Mendell (205_CR37) 2017; 377 SL Maude (205_CR11) 2018; 378 JE Rabinowitz (205_CR82) 2004; 78 CE Dunbar (205_CR4) 2018; 359 Z Wu (205_CR23) 2008; 16 MA Kay (205_CR7) 2011; 12 LA George (205_CR25) 2017; 377 BE Deverman (205_CR75) 2016; 34 GQ Perrin (205_CR173) 2019; 133 BE Deverman (205_CR34) 2018; 17 S Li (205_CR158) 2015; 23 J Korbelin (205_CR67) 2016; 24 YS Tseng (205_CR119) 2015; 89 L Wang (205_CR159) 2015; 23 J Fakhiri (205_CR52) 2019; 12 DA Waterkamp (205_CR124) 2006; 8 S Zolotukhin (205_CR143) 1999; 6 B Greenberg (205_CR181) 2016; 387 D D'Avola (205_CR183) 2016; 65 C Li (205_CR126) 2016; 24 J Denard (205_CR91) 2012; 86 S Kronenberg (205_CR21) 2005; 79 W Miesbach (205_CR174) 2018; 131 WW Zhang (205_CR185) 2018; 29 AC Nathwani (205_CR28) 2011; 365 P Tornabene (205_CR55) 2019; 11 Y Matsuzaki (205_CR153) 2018; 665 CH Srivastava (205_CR53) 1989; 86 BE Deverman (205_CR175) 2018; 17 AM Mitchell (205_CR85) 2013; 87 AM Keeler (205_CR12) 2019; 6 PE Monahan (205_CR84) 2010; 18 K Ishikawa (205_CR180) 2018; 123 L Govindasamy (205_CR16) 2006; 80 205_CR121 K Lundstrom (205_CR6) 2018; 6 AT Martino (205_CR131) 2013; 121 D Duan (205_CR47) 2001; 4 AC Nathwani (205_CR27) 2014; 371 AK Bevan (205_CR98) 2011; 19 Y Xiao (205_CR108) 2019; 4 RM Kotin (205_CR136) 2017; 28 NA Moore (205_CR1) 2017; 17 E Zinn (205_CR79) 2015; 12 J Korbelin (205_CR69) 2016; 8 O Kondratov (205_CR138) 2017; 25 JT Koerber (205_CR148) 2007; 18 |
| References_xml | – volume: 371 start-page: 1994 year: 2014 end-page: 2004 ident: CR27 article-title: Long-term safety and efficacy of factor IX gene therapy in hemophilia B publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1407309 – volume: 189 start-page: 43 year: 2018 end-page: 51 ident: CR186 article-title: Evolutionary basis of a new gene- and immune-therapeutic approach for the treatment of malignant brain tumors: from mice to clinical trials for glioma patients publication-title: Clin. Immunol. doi: 10.1016/j.clim.2017.07.006 – volume: 19 start-page: 1999 year: 2011 end-page: 2011 ident: CR156 article-title: Systemic administration of AAV8–α-galactosidase A induces humoral tolerance in nonhuman primates despite low hepatic expression publication-title: Mol. Ther. doi: 10.1038/mt.2011.119 – volume: 26 start-page: 289 year: 2018 end-page: 303 ident: CR127 article-title: Bioengineered AAV capsids with combined high human liver transduction in vivo and unique humoral seroreactivity publication-title: Mol. Ther. doi: 10.1016/j.ymthe.2017.09.021 – volume: 6 start-page: 601 year: 2019 end-page: 621 ident: CR12 article-title: Recombinant adeno-associated virus gene therapy in light of Luxturna (and Zolgensma and Glybera): where are we, and how did we get here? publication-title: Annu. Rev. Virol. doi: 10.1146/annurev-virology-092818-015530 – volume: 20 start-page: 1172 year: 2017 end-page: 1179 ident: CR76 article-title: Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems publication-title: Nat. Neurosci. doi: 10.1038/nn.4593 – volume: 1382 start-page: 21 year: 2016 end-page: 39 ident: CR48 article-title: Delivering transgenic DNA exceeding the carrying capacity of AAV vectors publication-title: Methods Mol. Biol. doi: 10.1007/978-1-4939-3271-9_2 – volume: 105 start-page: 7827 year: 2008 end-page: 7832 ident: CR59 article-title: Next generation of adeno-associated virus 2 vectors: point mutations in tyrosines lead to high-efficiency transduction at lower doses publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.0802866105 – volume: 10 start-page: 291 year: 2018 end-page: 302 ident: CR96 article-title: AAV-8 and AAV-9 vectors cooperate with serum proteins differently than AAV-1 and AAV-6 publication-title: Mol. Ther. Methods Clin. Dev. doi: 10.1016/j.omtm.2018.08.001 – volume: 4 start-page: 43 year: 2017 end-page: 63 ident: CR184 article-title: Adenovirus-mediated gene delivery: potential applications for gene and cell-based therapies in the new era of personalized medicine publication-title: Genes Dis. doi: 10.1016/j.gendis.2017.04.001 – volume: 182 start-page: 6051 year: 2009 end-page: 6060 ident: CR110 article-title: Adeno-associated virus capsid structure drives CD4-dependent CD8 T cell response to vector encoded proteins publication-title: J. Immunol. doi: 10.4049/jimmunol.0803965 – volume: 372 start-page: 1920 year: 2015 end-page: 1926 ident: CR171 article-title: Improvement and decline in vision with gene therapy in childhood blindness publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1412965 – volume: 16 start-page: 124 year: 2008 end-page: 130 ident: CR51 article-title: A hybrid vector system expands adeno-associated viral vector packaging capacity in a transgene-independent manner publication-title: Mol. Ther. doi: 10.1038/sj.mt.6300322 – volume: 5 start-page: 189ra176 year: 2013 ident: CR77 article-title: In vivo-directed evolution of a new adeno-associated virus for therapeutic outer retinal gene delivery from the vitreous publication-title: Sci. Transl Med. doi: 10.1126/scitranslmed.3005708 – volume: 23 start-page: 1877 year: 2015 end-page: 1887 ident: CR159 article-title: Comparative study of liver gene transfer with AAV vectors based on natural and engineered AAV capsids publication-title: Mol. Ther. doi: 10.1038/mt.2015.179 – volume: 36 start-page: 29 year: 2018 ident: CR26 article-title: Pharmaceutical development of AAV-based gene therapy products for the eye publication-title: Pharm. Res. doi: 10.1007/s11095-018-2554-7 – volume: 86 start-page: 6620 year: 2012 end-page: 6631 ident: CR91 article-title: Human galectin 3 binding protein interacts with recombinant adeno-associated virus type 6 publication-title: J. Virol. doi: 10.1128/JVI.00297-12 – volume: 4 start-page: 165ra163 year: 2012 ident: CR177 article-title: Long-term follow-up after gene therapy for canavan disease publication-title: Sci. Transl Med. doi: 10.1126/scitranslmed.3003454 – volume: 24 start-page: 49 year: 2017 end-page: 59 ident: CR93 article-title: Direct interaction of human serum proteins with AAV virions to enhance AAV transduction: immediate impact on clinical applications publication-title: Gene Ther. doi: 10.1038/gt.2016.75 – volume: 29 start-page: 160 year: 2018 end-page: 179 ident: CR185 article-title: The first approved gene therapy product for cancer Ad-p53 (Gendicine): 12 years in the clinic publication-title: Hum. Gene Ther. doi: 10.1089/hum.2017.218 – volume: 57 start-page: 3509 year: 2016 end-page: 3520 ident: CR167 article-title: Stem cell-derived photoreceptor transplants differentially integrate into mouse models of cone–rod dystrophy publication-title: Invest. Ophthalmol. Vis. Sci. doi: 10.1167/iovs.16-19087 – ident: CR121 – volume: 87 start-page: 10784 year: 2013 end-page: 10791 ident: CR92 article-title: C-reactive protein (CRP) is essential for efficient systemic transduction of recombinant adeno-associated virus vector 1 (rAAV-1) and rAAV-6 in mice publication-title: J. Virol. doi: 10.1128/JVI.01813-13 – volume: 387 start-page: 1178 year: 2016 end-page: 1186 ident: CR181 article-title: Calcium upregulation by percutaneous administration of gene therapy in patients with cardiac disease (CUPID 2): a randomised, multinational, double-blind, placebo-controlled, phase 2b trial publication-title: Lancet doi: 10.1016/S0140-6736(16)00082-9 – volume: 24 start-page: 94 year: 2015 end-page: 104 ident: CR17 article-title: Engineering the AAV capsid to optimize vector–host-interactions publication-title: Curr. Opin. Pharmacol. doi: 10.1016/j.coph.2015.08.002 – volume: 86 start-page: 8078 year: 1989 end-page: 8082 ident: CR53 article-title: Construction of a recombinant human parvovirus B19: adeno-associated virus 2 (AAV) DNA inverted terminal repeats are functional in an AAV–B19 hybrid virus publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.86.20.8078 – volume: 31 start-page: 741 year: 2013 end-page: 747 ident: CR166 article-title: Photoreceptor precursors derived from three-dimensional embryonic stem cell cultures integrate and mature within adult degenerate retina publication-title: Nat. Biotechnol. doi: 10.1038/nbt.2643 – volume: 9 start-page: 119 year: 2018 end-page: 129 ident: CR97 article-title: Influence of pre-existing anti-capsid neutralizing and binding antibodies on AAV vector transduction publication-title: Mol. Ther. Methods Clin. Dev. doi: 10.1016/j.omtm.2018.02.003 – volume: 18 start-page: 1907 year: 2010 end-page: 1916 ident: CR84 article-title: Proteasome inhibitors enhance gene delivery by AAV virus vectors expressing large genomes in hemophilia mouse and dog models: a strategy for broad clinical application publication-title: Mol. Ther. doi: 10.1038/mt.2010.170 – volume: 23 start-page: 1867 year: 2015 end-page: 1876 ident: CR158 article-title: Efficient and targeted transduction of nonhuman primate liver with systemically delivered optimized AAV3B vectors publication-title: Mol. Ther. doi: 10.1038/mt.2015.174 – volume: 35 start-page: 280 year: 2017 end-page: 284 ident: CR80 article-title: A synthetic AAV vector enables safe and efficient gene transfer to the mammalian inner ear publication-title: Nat. Biotechnol. doi: 10.1038/nbt.3781 – volume: 665 start-page: 182 year: 2018 end-page: 188 ident: CR153 article-title: Intravenous administration of the adeno-associated virus-PHP.B capsid fails to upregulate transduction efficiency in the marmoset brain publication-title: Neurosci. Lett. doi: 10.1016/j.neulet.2017.11.049 – volume: 35 start-page: 264 year: 2017 end-page: 272 ident: CR81 article-title: Gene therapy restores auditory and vestibular function in a mouse model of Usher syndrome type 1c publication-title: Nat. Biotechnol. doi: 10.1038/nbt.3801 – volume: 28 start-page: 1061 year: 2017 end-page: 1074 ident: CR117 article-title: Unraveling the complex story of immune responses to AAV vectors trial after trial publication-title: Hum. Gene Ther. doi: 10.1089/hum.2017.150 – volume: 11 start-page: 40 year: 2018 end-page: 51 ident: CR141 article-title: Development of a novel recombinant adeno-associated virus production system using human bocavirus 1 helper genes publication-title: Mol. Ther. Methods Clin. Dev. doi: 10.1016/j.omtm.2018.09.005 – volume: 9 start-page: 737 year: 2017 end-page: 740 ident: CR10 article-title: Gene therapy for ADA-SCID, the first marketing approval of an ex vivo gene therapy in Europe: paving the road for the next generation of advanced therapy medicinal products publication-title: EMBO Mol. Med. doi: 10.15252/emmm.201707573 – volume: 26 start-page: 304 year: 2018 end-page: 319 ident: CR73 article-title: In vivo selection of a computationally designed SCHEMA AAV library yields a novel variant for infection of adult neural stem cells in the SVZ publication-title: Mol. Ther. doi: 10.1016/j.ymthe.2017.09.006 – volume: 12 start-page: 342 year: 2006 end-page: 347 ident: CR29 article-title: Successful transduction of liver in hemophilia by AAV–factor IX and limitations imposed by the host immune response publication-title: Nat. Med. doi: 10.1038/nm1358 – volume: 28 start-page: 392 year: 2017 end-page: 402 ident: CR38 article-title: Characterization of adeno-associated viral vector-mediated human factor VIII gene therapy in hemophilia A mice publication-title: Hum. Gene Ther. doi: 10.1089/hum.2016.128 – volume: 430 start-page: 2626 year: 2018 end-page: 2640 ident: CR56 article-title: High-throughput dissection of AAV–host interactions: the fast and the curious publication-title: J. Mol. Biol. doi: 10.1016/j.jmb.2018.05.022 – volume: 363 start-page: 1429 year: 2010 end-page: 1437 ident: CR24 article-title: Dystrophin immunity in Duchenne’s muscular dystrophy publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1000228 – volume: 365 start-page: 2357 year: 2011 end-page: 2365 ident: CR28 article-title: Adenovirus-associated virus vector-mediated gene transfer in hemophilia B publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1108046 – volume: 26 start-page: 2337 year: 2018 end-page: 2356 ident: CR178 article-title: Micro-dystrophin gene therapy for duchenne muscular dystrophy publication-title: Mol. Ther. doi: 10.1016/j.ymthe.2018.07.011 – volume: 17 start-page: 63 year: 2015 end-page: 89 ident: CR5 article-title: Viral vectors for gene therapy: translational and clinical outlook publication-title: Annu. Rev. Biomed. Eng. doi: 10.1146/annurev-bioeng-071813-104938 – volume: 14 year: 2018 ident: CR122 article-title: Creating an arsenal of adeno-associated virus (AAV) gene delivery stealth vehicles publication-title: PLOS Pathog. doi: 10.1371/journal.ppat.1006929 – volume: 24 start-page: 545 year: 2013 end-page: 553 ident: CR32 article-title: Kinetics of adeno-associated virus serotype 2 (AAV2) and AAV8 capsid antigen presentation in vivo are identical publication-title: Hum. Gene Ther. doi: 10.1089/hum.2013.065 – volume: 176 start-page: 71 year: 2018 end-page: 83 ident: CR100 article-title: Blood–brain barrier shuttle peptides enhance AAV transduction in the brain after systemic administration publication-title: Biomaterials doi: 10.1016/j.biomaterials.2018.05.041 – volume: 11 start-page: 493 year: 2009 end-page: 503 ident: CR104 article-title: Evading the immune response upon in vivo gene therapy with viral vectors publication-title: Curr. Opin. Mol. Ther. – volume: 25 start-page: 1387 year: 2017 end-page: 1394 ident: CR182 article-title: 5 Year expression and neutrophil defect repair after gene therapy in α-1 antitrypsin deficiency publication-title: Mol. Ther. doi: 10.1016/j.ymthe.2017.03.029 – volume: 17 start-page: 641 year: 2018 end-page: 659 ident: CR175 article-title: Gene therapy for neurological disorders: progress and prospects publication-title: Nat. Rev. Drug. Discov. doi: 10.1038/nrd.2018.110 – volume: 107 start-page: 2653 year: 2006 end-page: 2661 ident: CR31 article-title: Self-complementary adeno-associated virus vectors containing a novel liver-specific human factor IX expression cassette enable highly efficient transduction of murine and nonhuman primate liver publication-title: Blood doi: 10.1182/blood-2005-10-4035 – volume: 23 start-page: 43 year: 2015 end-page: 52 ident: CR41 article-title: Genome-wide computational analysis reveals cardiomyocyte-specific transcriptional -regulatory motifs that enable efficient cardiac gene therapy publication-title: Mol. Ther. doi: 10.1038/mt.2014.178 – volume: 50 start-page: 567 year: 2019 end-page: 575.e5 ident: CR2 article-title: Adeno-associated virus delivery of anti-HIV monoclonal antibodies can drive long-term virologic suppression publication-title: Immunity doi: 10.1016/j.immuni.2019.02.005 – volume: 23 start-page: 3180 year: 2014 end-page: 3188 ident: CR163 article-title: Human skeletal muscle xenograft as a new preclinical model for muscle disorders publication-title: Hum. Mol. Genet. doi: 10.1093/hmg/ddu028 – volume: 25 start-page: 98 year: 2014 end-page: 108 ident: CR49 article-title: Triple -splicing adeno-associated virus vectors capable of transferring the coding sequence for full-length dystrophin protein into dystrophic mice publication-title: Hum. Gene Ther. doi: 10.1089/hum.2013.164 – volume: 15 start-page: 445 year: 2014 end-page: 451 ident: CR18 article-title: Engineering adeno-associated viruses for clinical gene therapy publication-title: Nat. Rev. Genet. doi: 10.1038/nrg3742 – volume: 19 start-page: 1971 year: 2011 end-page: 1980 ident: CR98 article-title: Systemic gene delivery in large species for targeting spinal cord, brain, and peripheral tissues for pediatric disorders publication-title: Mol. Ther. doi: 10.1038/mt.2011.157 – volume: 6 start-page: 613 year: 1997 end-page: 621 ident: CR105 article-title: The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP publication-title: Immunity doi: 10.1016/S1074-7613(00)80349-0 – volume: 24 start-page: 104 year: 2013 end-page: 116 ident: CR130 article-title: Targeted modifications in adeno-associated virus serotype 8 capsid improves its hepatic gene transfer efficiency in vivo publication-title: Hum. Gene Ther. Methods doi: 10.1089/hgtb.2012.195 – volume: 166 start-page: 263 year: 2016 ident: CR187 article-title: Gene therapy for “Bubble Boy” disease publication-title: Cell doi: 10.1016/j.cell.2016.06.049 – volume: 21 start-page: 1040 year: 2003 end-page: 1046 ident: CR66 article-title: Random peptide libraries displayed on adeno-associated virus to select for targeted gene therapy vectors publication-title: Nat. Biotechnol. doi: 10.1038/nbt856 – volume: 24 start-page: 53 year: 2016 end-page: 65 ident: CR126 article-title: Development of patient-specific AAV vectors after neutralizing antibody selection for enhanced muscle gene transfer publication-title: Mol. Ther. doi: 10.1038/mt.2015.134 – volume: 377 start-page: 1713 year: 2017 end-page: 1722 ident: CR37 article-title: Single-dose gene-replacement therapy for spinal muscular atrophy publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1706198 – volume: 9 start-page: 2745 year: 1998 end-page: 2760 ident: CR145 article-title: Novel tools for production and purification of recombinant adenoassociated virus vectors publication-title: Hum. Gene Ther. doi: 10.1089/hum.1998.9.18-2745 – volume: 22 start-page: 1605 year: 2014 end-page: 1613 ident: CR40 article-title: Liver-specific transcriptional modules identified by genome-wide in silico analysis enable efficient gene therapy in mice and non-human primates publication-title: Mol. Ther. doi: 10.1038/mt.2014.114 – volume: 34 start-page: 204 year: 2016 end-page: 209 ident: CR75 article-title: Cre-dependent selection yields AAV variants for widespread gene transfer to the adult brain publication-title: Nat. Biotechnol. doi: 10.1038/nbt.3440 – volume: 2 start-page: 15040 year: 2015 ident: CR149 article-title: Identification of an adeno-associated virus binding epitope for AVB Sepharose affinity resin publication-title: Mol. Ther. Methods Clin. Dev. doi: 10.1038/mtm.2015.40 – volume: 123 start-page: 2994 year: 2013 end-page: 3001 ident: CR113 article-title: CpG-depleted adeno-associated virus vectors evade immune detection publication-title: J. Clin. Invest. doi: 10.1172/JCI68205 – volume: 18 start-page: 681 year: 2018 end-page: 693 ident: CR179 article-title: The progress of AAV-mediated gene therapy in neuromuscular disorders publication-title: Expert Opin. Biol. Ther. doi: 10.1080/14712598.2018.1479739 – volume: 20 start-page: 1831 year: 2012 end-page: 1832 ident: CR9 article-title: Endgame: Glybera finally recommended for approval as the first gene therapy drug in the European Union publication-title: Mol. Ther. doi: 10.1038/mt.2012.194 – volume: 17 start-page: 463 year: 2009 end-page: 471 ident: CR60 article-title: High-efficiency transduction of the mouse retina by tyrosine-mutant AAV serotype vectors publication-title: Mol. Ther. doi: 10.1038/mt.2008.269 – volume: 3 year: 2018 ident: CR33 article-title: Double-stranded RNA innate immune response activation from long-term adeno-associated virus vector transduction publication-title: JCI Insight doi: 10.1172/jci.insight.120474 – volume: 288 start-page: 28814 year: 2013 end-page: 28823 ident: CR57 article-title: Engraftment of a galactose receptor footprint onto adeno-associated viral capsids improves transduction efficiency publication-title: J. Biol. Chem. doi: 10.1074/jbc.M113.482380 – volume: 9 start-page: 33 year: 2018 end-page: 46 ident: CR152 article-title: Universal method for the purification of recombinant AAV vectors of differing serotypes publication-title: Mol. Ther. Methods Clin. Dev. doi: 10.1016/j.omtm.2017.12.004 – volume: 5 start-page: 1 year: 2013 end-page: 3 ident: CR8 article-title: Gene therapy enters the pharma market: the short story of a long journey publication-title: EMBO Mol. Med. doi: 10.1002/emmm.201202291 – volume: 99 start-page: 10405 year: 2002 end-page: 10410 ident: CR15 article-title: The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.162250899 – volume: 23 start-page: 1800 year: 2015 end-page: 1801 ident: CR162 article-title: Selecting the best AAV capsid for human studies publication-title: Mol. Ther. doi: 10.1038/mt.2015.206 – volume: 35 start-page: 691 year: 2017 end-page: 693 ident: CR188 article-title: First approval in sight for Novartis’ CAR-T therapy after panel vote publication-title: Nat. Biotechnol. doi: 10.1038/nbt0817-691 – volume: 18 start-page: 367 year: 2007 end-page: 378 ident: CR148 article-title: Engineering adeno-associated virus for one-step purification via immobilized metal affinity chromatography publication-title: Hum. Gene Ther. doi: 10.1089/hum.2006.139 – volume: 89 start-page: 1794 year: 2015 end-page: 1808 ident: CR119 article-title: Adeno-associated virus serotype 1 (AAV1)– and AAV5–antibody complex structures reveal evolutionary commonalities in parvovirus antigenic reactivity publication-title: J. Virol. doi: 10.1128/JVI.02710-14 – volume: 15 year: 2017 ident: CR155 article-title: Evaluation of engineered AAV capsids for hepatic factor IX gene transfer in murine and canine models publication-title: J. Transl Med. doi: 10.1186/s12967-017-1200-1 – volume: 24 start-page: 287 year: 2016 end-page: 297 ident: CR134 article-title: Production of recombinant adeno-associated virus vectors using suspension HEK293 cells and continuous harvest of vector from the culture media for GMP FIX and FLT1 clinical vector publication-title: Mol. Ther. doi: 10.1038/mt.2015.187 – volume: 14 start-page: 77 year: 2019 end-page: 89 ident: CR90 article-title: Enhancement of adeno-associated virus-mediated gene therapy using hydroxychloroquine in murine and human tissues publication-title: Mol. Ther. Methods Clin. Dev. doi: 10.1016/j.omtm.2019.05.012 – volume: 5 start-page: 194ra192 year: 2013 ident: CR151 article-title: Overcoming preexisting humoral immunity to AAV using capsid decoys publication-title: Sci. Transl Med. doi: 10.1126/scitranslmed.3005795 – volume: 78 start-page: 4421 year: 2004 end-page: 4432 ident: CR82 article-title: Cross-dressing the virion: the transcapsidation of adeno-associated virus serotypes functionally defines subgroups publication-title: J. Virol. doi: 10.1128/JVI.78.9.4421-4432.2004 – volume: 17 start-page: 1235 year: 2017 end-page: 1244 ident: CR1 article-title: Gene therapy for age-related macular degeneration publication-title: Expert. Opin. Biol. Ther. doi: 10.1080/14712598.2017.1356817 – volume: 10 start-page: 2112 year: 2003 end-page: 2118 ident: CR35 article-title: Adeno-associated virus terminal repeat (TR) mutant generates self-complementary vectors to overcome the rate-limiting step to transduction in vivo publication-title: Gene Ther. doi: 10.1038/sj.gt.3302134 – volume: 6 start-page: 42 year: 2018 ident: CR6 article-title: Viral vectors in gene therapy publication-title: Diseases doi: 10.3390/diseases6020042 – volume: 4 year: 2019 ident: CR108 article-title: Circumventing cellular immunity by miR142-mediated regulation sufficiently supports rAAV-delivered OVA expression without activating humoral immunity publication-title: JCI Insight doi: 10.1172/jci.insight.99052 – volume: 25 start-page: 212 year: 2014 end-page: 222 ident: CR137 article-title: OneBac: platform for scalable and high-titer production of adeno-associated virus serotype 1–12 vectors for gene therapy publication-title: Hum. Gene Ther. doi: 10.1089/hum.2013.184 – volume: 8 start-page: 166 year: 2018 end-page: 180 ident: CR135 article-title: Pharmacology of recombinant adeno-associated virus production publication-title: Mol. Ther. Methods Clin. Dev. doi: 10.1016/j.omtm.2018.01.002 – volume: 28 start-page: 654 year: 2017 end-page: 666 ident: CR103 article-title: Gene delivery of activated factor VII using alternative adeno-associated virus serotype improves hemostasis in hemophiliac mice with FVIII inhibitors and adeno-associated virus neutralizing antibodies publication-title: Hum. Gene Ther. doi: 10.1089/hum.2017.016 – volume: 260 start-page: 805 year: 1976 end-page: 806 ident: CR42 article-title: Quantitative adaptation of isoacceptor tRNAs to mRNA codons of alanine, glycine and serine publication-title: Nature doi: 10.1038/260805a0 – volume: 262 start-page: 348 year: 2017 end-page: 356 ident: CR83 article-title: Application of polyploid adeno-associated virus vectors for transduction enhancement and neutralizing antibody evasion publication-title: J. Control Rel. doi: 10.1016/j.jconrel.2017.08.005 – volume: 82 start-page: 2727 year: 2008 end-page: 2740 ident: CR168 article-title: Complement is an essential component of the immune response to adeno-associated virus vectors publication-title: J. Virol. doi: 10.1128/JVI.01990-07 – volume: 132 start-page: 777 year: 2018 end-page: 781 ident: CR189 article-title: Translating anti-CD19 CAR T-cell therapy into clinical practice for relapsed/refractory diffuse large B-cell lymphoma publication-title: Blood doi: 10.1182/blood-2018-04-839217 – volume: 6 start-page: 973 year: 1999 end-page: 985 ident: CR143 article-title: Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield publication-title: Gene Ther. doi: 10.1038/sj.gt.3300938 – volume: 90 start-page: 7019 year: 2016 end-page: 7031 ident: CR87 article-title: Identification and validation of small molecules that enhance recombinant adeno-associated virus transduction following high-throughput screens publication-title: J. Virol. doi: 10.1128/JVI.02953-15 – volume: 10 start-page: 257 year: 2018 end-page: 267 ident: CR102 article-title: An observational study from long-term AAV re-administration in two hemophilia dogs publication-title: Mol. Ther. Methods Clin. Dev. doi: 10.1016/j.omtm.2018.07.011 – volume: 24 start-page: 1519 year: 2018 end-page: 1525 ident: CR54 article-title: Treatment of a metabolic liver disease by in vivo genome base editing in adult mice publication-title: Nat. Med. doi: 10.1038/s41591-018-0209-1 – volume: 26 start-page: 457 year: 2018 end-page: 458 ident: CR114 article-title: Engineering AAV vectors to evade innate immune and inflammatory responses publication-title: Mol. Ther. – volume: 140 start-page: 183 year: 2007 end-page: 192 ident: CR150 article-title: Separation of adeno-associated virus type 2 empty particles from genome containing vectors by anion-exchange column chromatography publication-title: J. Virol. Methods doi: 10.1016/j.jviromet.2006.11.019 – volume: 260 start-page: 649 year: 1996 end-page: 663 ident: CR43 article-title: Co-variation of tRNA abundance and codon usage in at different growth rates publication-title: J. Mol. Biol. doi: 10.1006/jmbi.1996.0428 – volume: 121 start-page: 2224 year: 2013 end-page: 2233 ident: CR131 article-title: Engineered AAV vector minimizes in vivo targeting of transduced hepatocytes by capsid-specific CD8 T cells publication-title: Blood doi: 10.1182/blood-2012-10-460733 – volume: 8 start-page: 609 year: 2016 end-page: 625 ident: CR69 article-title: A brain microvasculature endothelial cell-specific viral vector with the potential to treat neurovascular and neurological diseases publication-title: EMBO Mol. Med. doi: 10.15252/emmm.201506078 – volume: 22 start-page: 1900 year: 2014 end-page: 1909 ident: CR74 article-title: Vector design tour de force: integrating combinatorial and rational approaches to derive novel adeno-associated virus variants publication-title: Mol. Ther. doi: 10.1038/mt.2014.139 – volume: 359 year: 2018 ident: CR4 article-title: Gene therapy comes of age publication-title: Science doi: 10.1126/science.aan4672 – volume: 378 start-page: 439 year: 2018 end-page: 448 ident: CR11 article-title: Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1709866 – volume: 26 start-page: 334 year: 2015 end-page: 346 ident: CR39 article-title: Optimization of recombinant adeno-associated virus-mediated expression for large transgenes, using a synthetic promoter and tandem array enhancers publication-title: Hum. Gene Ther. doi: 10.1089/hum.2015.001 – volume: 25 start-page: 415 year: 2018 end-page: 424 ident: CR139 article-title: Optimization of viral protein ratios for production of rAAV serotype 5 in the baculovirus system publication-title: Gene Ther. doi: 10.1038/s41434-018-0034-7 – volume: 74 start-page: 8732 year: 2000 end-page: 8739 ident: CR22 article-title: Novel transcriptional regulatory signals in the adeno-associated virus terminal repeat A/D junction element publication-title: J. Virol. doi: 10.1128/JVI.74.18.8732-8739.2000 – volume: 17 start-page: 767 year: 2018 ident: CR34 article-title: Gene therapy for neurological disorders: progress and prospects publication-title: Nat. Rev. Drug. Discov. doi: 10.1038/nrd.2018.158 – volume: 518 start-page: 95 year: 2018 end-page: 102 ident: CR94 article-title: AAV8 virions hijack serum proteins to increase hepatocyte binding for transduction enhancement publication-title: Virology doi: 10.1016/j.virol.2018.02.007 – volume: 24 start-page: 59 year: 2013 end-page: 67 ident: CR116 article-title: Pre-existing anti-adeno-associated virus antibodies as a challenge in AAV gene therapy publication-title: Hum. Gene Ther. Methods doi: 10.1089/hgtb.2012.243 – volume: 20 start-page: 767 year: 2009 end-page: 776 ident: CR109 article-title: Improved induction of immune tolerance to factor IX by hepatic AAV-8 gene transfer publication-title: Hum. Gene Ther. doi: 10.1089/hum.2008.161 – volume: 28 start-page: 350 year: 2017 end-page: 360 ident: CR136 article-title: Manufacturing clinical grade recombinant adeno-associated virus using invertebrate cell lines publication-title: Hum. Gene Ther. doi: 10.1089/hum.2017.042 – volume: 123 start-page: 601 year: 2018 end-page: 613 ident: CR180 article-title: Human cardiac gene therapy publication-title: Circ. Res. doi: 10.1161/CIRCRESAHA.118.311587 – volume: 27 start-page: 601 year: 2018 end-page: 613 ident: CR107 article-title: Inhibition of antigen presentation during AAV gene therapy using virus peptides publication-title: Hum. Mol. Genet. doi: 10.1093/hmg/ddx427 – volume: 26 start-page: 504 year: 2019 end-page: 514 ident: CR161 article-title: Superior human hepatocyte transduction with adeno-associated virus vector serotype 7 publication-title: Gene Ther. doi: 10.1038/s41434-019-0104-5 – volume: 8 start-page: 911 year: 2003 end-page: 917 ident: CR36 article-title: Self-complementary adeno-associated virus serotype 2 vector: global distribution and broad dispersion of AAV-mediated transgene expression in mouse brain publication-title: Mol. Ther. doi: 10.1016/j.ymthe.2003.08.021 – volume: 133 start-page: 407 year: 2019 end-page: 414 ident: CR173 article-title: Update on clinical gene therapy for hemophilia publication-title: Blood doi: 10.1182/blood-2018-07-820720 – volume: 18 start-page: 37 year: 2018 end-page: 49 ident: CR169 article-title: Gene therapy for inherited retinal and optic nerve degenerations publication-title: Expert. Opin. Biol. Ther. doi: 10.1080/14712598.2018.1389886 – volume: 14 start-page: 316 year: 2006 end-page: 327 ident: CR13 article-title: Adeno-associated virus serotypes: vector toolkit for human gene therapy publication-title: Mol. Ther. doi: 10.1016/j.ymthe.2006.05.009 – volume: 119 start-page: 2388 year: 2009 end-page: 2398 ident: CR111 article-title: The TLR9–MyD88 pathway is critical for adaptive immune responses to adeno-associated virus gene therapy vectors in mice publication-title: J. Clin. Invest. doi: 10.1172/JCI37607 – volume: 1 start-page: 265 year: 2017 end-page: 273 ident: CR176 article-title: Efficacy and safety of AAV2 gene therapy in children with aromatic L-amino acid decarboxylase deficiency: an open-label, phase 1/2 trial publication-title: Lancet. Child. Adolesc. Health doi: 10.1016/S2352-4642(17)30125-6 – volume: 65 start-page: 776 year: 2016 end-page: 783 ident: CR183 article-title: Phase I open label liver-directed gene therapy clinical trial for acute intermittent porphyria publication-title: J. Hepatol. doi: 10.1016/j.jhep.2016.05.012 – volume: 9 start-page: 234 year: 2018 end-page: 246 ident: CR58 article-title: A rationally engineered capsid variant of AAV9 for systemic CNS-directed and peripheral tissue-detargeted gene delivery in neonates publication-title: Mol. Ther. Methods Clin. Dev. doi: 10.1016/j.omtm.2018.03.004 – volume: 8 start-page: 1307 year: 2006 end-page: 1319 ident: CR124 article-title: Isolation of targeted AAV2 vectors from novel virus display libraries publication-title: J. Gene Med. doi: 10.1002/jgm.967 – volume: 19 start-page: 671 year: 2018 end-page: 687 ident: CR165 article-title: Progress and potential in organoid research publication-title: Nat. Rev. Genet. doi: 10.1038/s41576-018-0051-9 – volume: 106 start-page: 10770 year: 2009 end-page: 10774 ident: CR101 article-title: Cellular immune response to cryptic epitopes during therapeutic gene transfer publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.0902269106 – volume: 26 start-page: 257 year: 2015 end-page: 265 ident: CR14 article-title: Adeno-associated virus at 50: a golden anniversary of discovery, research, and gene therapy success — a personal perspective publication-title: Hum. Gene Ther. doi: 10.1089/hum.2015.025 – volume: 2 year: 2006 ident: CR44 article-title: Tissue-specific differences in human transfer RNA expression publication-title: PLOS Genet. doi: 10.1371/journal.pgen.0020221 – volume: 131 start-page: 1022 year: 2018 end-page: 1031 ident: CR174 article-title: Gene therapy with adeno-associated virus vector 5-human factor IX in adults with hemophilia B publication-title: Blood doi: 10.1182/blood-2017-09-804419 – volume: 24 start-page: 1050 year: 2016 end-page: 1061 ident: CR67 article-title: Pulmonary targeting of adeno-associated viral vectors by next-generation sequencing-guided screening of random capsid displayed peptide libraries publication-title: Mol. Ther. doi: 10.1038/mt.2016.62 – volume: 291 start-page: 939 year: 2016 end-page: 947 ident: CR88 article-title: Chemical modulation of endocytic sorting augments adeno-associated viral transduction publication-title: J. Biol. Chem. doi: 10.1074/jbc.M115.687657 – volume: 87 start-page: 4571 year: 2013 end-page: 4583 ident: CR86 article-title: Arsenic trioxide stabilizes accumulations of adeno-associated virus virions at the perinuclear region, increasing transduction in vitro and in vivo publication-title: J. Virol. doi: 10.1128/JVI.03443-12 – volume: 15 start-page: 3247 year: 1996 end-page: 3255 ident: CR106 article-title: Molecular mechanism and species specificity of TAP inhibition by herpes simplex virus ICP47 publication-title: EMBO J. doi: 10.1002/j.1460-2075.1996.tb00689.x – volume: 25 start-page: 2648 year: 2017 end-page: 2660 ident: CR115 article-title: AAV8 can induce innate and adaptive immune response in the primate eye publication-title: Mol. Ther. doi: 10.1016/j.ymthe.2017.08.018 – volume: 27 start-page: 143 year: 2016 end-page: 149 ident: CR62 article-title: Development of optimized AAV serotype vectors for high-efficiency transduction at further reduced doses publication-title: Hum. Gene Ther. Methods doi: 10.1089/hgtb.2016.054 – volume: 22 start-page: 934 year: 2015 end-page: 946 ident: CR78 article-title: AAV ancestral reconstruction library enables selection of broadly infectious viral variants publication-title: Gene Ther. doi: 10.1038/gt.2015.74 – volume: 87 start-page: 13035 year: 2013 end-page: 13041 ident: CR85 article-title: Mechanistic insights into the enhancement of adeno-associated virus transduction by proteasome inhibitors publication-title: J. Virol. doi: 10.1128/JVI.01826-13 – volume: 9 start-page: 844 year: 2018 ident: CR129 article-title: Efficient capsid antigen presentation from adeno-associated virus empty virions publication-title: Vivo. Front. Immunol. doi: 10.3389/fimmu.2018.00844 – volume: 17 start-page: 1888 year: 2009 end-page: 1896 ident: CR146 article-title: A simplified baculovirus–AAV expression vector system coupled with one-step affinity purification yields high-titer rAAV stocks from insect cells publication-title: Mol. Ther. doi: 10.1038/mt.2009.128 – volume: 114 start-page: E4812 year: 2017 end-page: E4821 ident: CR123 article-title: Structure-guided evolution of antigenically distinct adeno-associated virus variants for immune evasion publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1704766114 – volume: 377 start-page: 2519 year: 2017 end-page: 2530 ident: CR30 article-title: AAV5–factor VIII gene transfer in severe hemophilia A publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1708483 – volume: 14 start-page: 97 year: 2006 end-page: 106 ident: CR147 article-title: Metabolic biotinylation provides a unique platform for the purification and targeting of multiple AAV vector serotypes publication-title: Mol. Ther. doi: 10.1016/j.ymthe.2006.02.014 – volume: 7 start-page: 146 year: 2017 end-page: 156 ident: CR140 article-title: A robust system for production of superabundant VP1 recombinant AAV vectors publication-title: Mol. Ther. Methods Clin. Dev. doi: 10.1016/j.omtm.2017.11.002 – volume: 4 start-page: 372 year: 2001 end-page: 374 ident: CR144 article-title: A single-step affinity column for purification of serotype-5 based adeno-associated viral vectors publication-title: Mol. Ther. doi: 10.1006/mthe.2001.0462 – volume: 117 start-page: 6459 year: 2011 end-page: 6468 ident: CR112 article-title: The genome of self-complementary adeno-associated viral vectors increases Toll-like receptor 9-dependent innate immune responses in the liver publication-title: Blood doi: 10.1182/blood-2010-10-314518 – volume: 79 start-page: 5296 year: 2005 end-page: 5303 ident: CR21 article-title: A conformational change in the adeno-associated virus type 2 capsid leads to the exposure of hidden VP1 N termini publication-title: J. Virol. doi: 10.1128/JVI.79.9.5296-5303.2005 – volume: 9 start-page: 57 year: 2018 end-page: 69 ident: CR45 article-title: Target-cell-directed bioengineering approaches for gene therapy of hemophilia A publication-title: Mol. Ther. Methods Clin. Dev. doi: 10.1016/j.omtm.2018.01.004 – volume: 29 start-page: 886 year: 2018 end-page: 901 ident: CR89 article-title: High-throughput screening identifies kinase inhibitors that increase dual adeno-associated viral vector transduction in vitro and in mouse retina publication-title: Hum. Gene Ther. doi: 10.1089/hum.2017.220 – volume: 12 start-page: 187 year: 2017 end-page: 215 ident: CR164 article-title: Humanized mouse models of clinical disease publication-title: Annu. Rev. Pathol. doi: 10.1146/annurev-pathol-052016-100332 – volume: 12 start-page: 1056 year: 2015 end-page: 1068 ident: CR79 article-title: In silico reconstruction of the viral evolutionary lineage yields a potent gene therapy vector publication-title: Cell Rep. doi: 10.1016/j.celrep.2015.07.019 – volume: 286 start-page: 415 year: 2018 end-page: 424 ident: CR95 article-title: Cryoprecipitate augments the global transduction of the adeno-associated virus serotype 9 after a systemic administration publication-title: J. Control Rel. doi: 10.1016/j.jconrel.2018.08.018 – volume: 24 start-page: 198 year: 2006 end-page: 204 ident: CR70 article-title: Directed evolution of adeno-associated virus yields enhanced gene delivery vectors publication-title: Nat. Biotechnol. doi: 10.1038/nbt1182 – volume: 123 start-page: 1390 year: 2013 end-page: 1401 ident: CR128 article-title: Adeno-associated virus capsid antigen presentation is dependent on endosomal escape publication-title: J. Clin. Invest. doi: 10.1172/JCI66611 – volume: 377 start-page: 2215 year: 2017 end-page: 2227 ident: CR25 article-title: Hemophilia B gene therapy with a high-specific-activity factor IX variant publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1708538 – volume: 16 start-page: 280 year: 2008 end-page: 289 ident: CR23 article-title: Optimization of self-complementary AAV vectors for liver-directed expression results in sustained correction of hemophilia B at low vector dose publication-title: Mol. Ther. doi: 10.1038/sj.mt.6300355 – volume: 21 start-page: 2205 year: 2013 end-page: 2216 ident: CR50 article-title: Oversized AAV transductifon is mediated via a DNA-PKcs-independent, Rad51C-dependent repair pathway publication-title: Mol. Ther. doi: 10.1038/mt.2013.184 – volume: 5 start-page: 31 year: 2010 end-page: 55 ident: CR65 article-title: A new recombinant adeno-associated virus (AAV)-based random peptide display library system: infection-defective AAV1.9-3 as a novel detargeted platform for vector evolution publication-title: Gene Ther. Regul. doi: 10.1142/S1568558610000197 – volume: 86 start-page: 7752 year: 2012 end-page: 7759 ident: CR120 article-title: Single amino acid modification of adeno-associated virus capsid changes transduction and humoral immune profiles publication-title: J. Virol. doi: 10.1128/JVI.00675-12 – volume: 18 start-page: 2048 year: 2010 end-page: 2056 ident: CR61 article-title: High-efficiency transduction and correction of murine hemophilia B using AAV2 vectors devoid of multiple surface-exposed tyrosines publication-title: Mol. Ther. doi: 10.1038/mt.2010.172 – volume: 19 start-page: 800 year: 2012 end-page: 809 ident: CR68 article-title: Novel random peptide libraries displayed on AAV serotype 9 for selection of endothelial cell-directed gene transfer vectors publication-title: Gene Ther. doi: 10.1038/gt.2011.143 – volume: 12 start-page: 316 year: 2011 end-page: 328 ident: CR7 article-title: State-of-the-art gene-based therapies: the road ahead publication-title: Nat. Rev. Genet. doi: 10.1038/nrg2971 – volume: 80 start-page: 11556 year: 2006 end-page: 11570 ident: CR16 article-title: Structurally mapping the diverse phenotype of adeno-associated virus serotype 4 publication-title: J. Virol. doi: 10.1128/JVI.01536-06 – volume: 506 start-page: 382 year: 2014 end-page: 386 ident: CR157 article-title: Selection and evaluation of clinically relevant AAV variants in a xenograft liver model publication-title: Nature doi: 10.1038/nature12875 – volume: 79 start-page: 2528 year: 2005 end-page: 2540 ident: CR20 article-title: Mutational analysis of narrow pores at the fivefold symmetry axes of adeno-associated virus type 2 capsids reveals a dual role in genome packaging and activation of phospholipase A2 activity publication-title: J. Virol. doi: 10.1128/JVI.79.4.2528-2540.2005 – volume: 19 start-page: 1070 year: 2011 end-page: 1078 ident: CR71 article-title: Engineering liver-detargeted AAV9 vectors for cardiac and musculoskeletal gene transfer publication-title: Mol. Ther. doi: 10.1038/mt.2011.22 – volume: 431 start-page: 40 year: 2012 end-page: 49 ident: CR118 article-title: Structure of adeno-associated virus-2 in complex with neutralizing monoclonal antibody A20 publication-title: Virology doi: 10.1016/j.virol.2012.05.004 – volume: 25 start-page: 2661 year: 2017 end-page: 2675 ident: CR138 article-title: Direct head-to-head evaluation of recombinant adeno-associated viral vectors manufactured in human versus insect cells publication-title: Mol. Ther. doi: 10.1016/j.ymthe.2017.08.003 – volume: 24 start-page: 124 year: 2017 end-page: 131 ident: CR19 article-title: Host determinants of adeno-associated viral vector entry publication-title: Curr. Opin. Virol. doi: 10.1016/j.coviro.2017.06.003 – volume: 20 start-page: 443 year: 2012 end-page: 455 ident: CR46 article-title: Phase 1 gene therapy for Duchenne muscular dystrophy using a translational optimized AAV vector publication-title: Mol. Ther. doi: 10.1038/mt.2011.237 – volume: 3 start-page: 964 year: 2001 end-page: 975 ident: CR64 article-title: Incorporation of tumor-targeting peptides into recombinant adeno-associated virus capsids publication-title: Mol. Ther. doi: 10.1006/mthe.2001.0345 – volume: 11 year: 2019 ident: CR55 article-title: Intein-mediated protein -splicing expands adeno-associated virus transfer capacity in the retina publication-title: Sci. Transl Med. doi: 10.1126/scitranslmed.aav4523 – volume: 20 start-page: R2 year: 2011 end-page: R6 ident: CR133 article-title: Large-scale recombinant adeno-associated virus production publication-title: Hum. Mol. Genet. doi: 10.1093/hmg/ddr141 – volume: 12 start-page: 202 year: 2019 end-page: 222 ident: CR52 article-title: Novel chimeric gene therapy vectors based on adeno-associated virus and four different mammalian bocaviruses publication-title: Mol. Ther. Methods Clin. Dev. doi: 10.1016/j.omtm.2019.01.003 – volume: 27 start-page: 1285 year: 2018 end-page: 1300 ident: CR3 article-title: Adeno-associated virus gene therapy: translational progress and future prospects in the treatment of heart failure publication-title: Heart Lung Circ. doi: 10.1016/j.hlc.2018.03.005 – volume: 109 start-page: 513 year: 2004 end-page: 519 ident: CR63 article-title: Targeted gene delivery to vascular tissue in vivo by tropism-modified adeno-associated virus vectors publication-title: Circulation doi: 10.1161/01.CIR.0000109697.68832.5D – volume: 372 start-page: 1887 year: 2015 end-page: 1897 ident: CR170 article-title: Long-term effect of gene therapy on Leber’s congenital amaurosis publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1414221 – volume: 1 start-page: 12 year: 2014 ident: CR99 article-title: Enhancing gene delivery of adeno-associated viruses by cell-permeable peptides publication-title: Mol. Ther. Methods Clin. Dev. doi: 10.1038/mtm.2013.12 – volume: 26 start-page: 664 year: 2018 end-page: 668 ident: CR154 article-title: The neurotropic properties of AAV-PHP.B are limited to C57BL/6J Mice publication-title: Mol. Ther. doi: 10.1016/j.ymthe.2018.01.018 – volume: 9 start-page: 553 year: 2002 end-page: 558 ident: CR72 article-title: Protein building blocks preserved by recombination publication-title: Nat. Struct. Biol. – year: 2017 ident: CR142 article-title: Human bocavirus 1 is a novel helper for adeno-associated virus replication publication-title: J. Virol. doi: 10.1128/JVI.00710-17 – volume: 24 start-page: 1042 year: 2016 end-page: 1049 ident: CR160 article-title: Superior in vivo transduction of human hepatocytes using engineered AAV3 capsid publication-title: Mol. Ther. doi: 10.1038/mt.2016.61 – volume: 4 start-page: 383 year: 2001 end-page: 391 ident: CR47 article-title: Expanding AAV packaging capacity with -splicing or overlapping vectors: a quantitative comparison publication-title: Mol. Ther. doi: 10.1006/mthe.2001.0456 – volume: 3 start-page: 166 year: 2018 end-page: 177 ident: CR132 article-title: How will the field of gene therapy survive its success? publication-title: Bioeng. Transl Med. doi: 10.1002/btm2.10090 – volume: 110 start-page: E517 year: 2013 end-page: E525 ident: CR172 article-title: Human retinal gene therapy for Leber congenital amaurosis shows advancing retinal degeneration despite enduring visual improvement publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1218933110 – volume: 82 start-page: 5887 year: 2008 end-page: 5911 ident: CR125 article-title: In vitro and in vivo gene therapy vector evolution via multispecies interbreeding and retargeting of adeno-associated viruses publication-title: J. Virol. doi: 10.1128/JVI.00254-08 – volume: 17 start-page: 463 year: 2009 ident: 205_CR60 publication-title: Mol. Ther. doi: 10.1038/mt.2008.269 – volume: 78 start-page: 4421 year: 2004 ident: 205_CR82 publication-title: J. Virol. doi: 10.1128/JVI.78.9.4421-4432.2004 – volume: 18 start-page: 367 year: 2007 ident: 205_CR148 publication-title: Hum. Gene Ther. doi: 10.1089/hum.2006.139 – volume: 110 start-page: E517 year: 2013 ident: 205_CR172 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1218933110 – volume: 17 start-page: 63 year: 2015 ident: 205_CR5 publication-title: Annu. Rev. Biomed. Eng. doi: 10.1146/annurev-bioeng-071813-104938 – volume: 15 year: 2017 ident: 205_CR155 publication-title: J. Transl Med. doi: 10.1186/s12967-017-1200-1 – volume: 2 year: 2006 ident: 205_CR44 publication-title: PLOS Genet. doi: 10.1371/journal.pgen.0020221 – volume: 288 start-page: 28814 year: 2013 ident: 205_CR57 publication-title: J. Biol. Chem. doi: 10.1074/jbc.M113.482380 – volume: 4 start-page: 383 year: 2001 ident: 205_CR47 publication-title: Mol. Ther. doi: 10.1006/mthe.2001.0456 – volume: 26 start-page: 257 year: 2015 ident: 205_CR14 publication-title: Hum. Gene Ther. doi: 10.1089/hum.2015.025 – volume: 131 start-page: 1022 year: 2018 ident: 205_CR174 publication-title: Blood doi: 10.1182/blood-2017-09-804419 – volume: 90 start-page: 7019 year: 2016 ident: 205_CR87 publication-title: J. Virol. doi: 10.1128/JVI.02953-15 – volume: 26 start-page: 664 year: 2018 ident: 205_CR154 publication-title: Mol. Ther. doi: 10.1016/j.ymthe.2018.01.018 – volume: 74 start-page: 8732 year: 2000 ident: 205_CR22 publication-title: J. Virol. doi: 10.1128/JVI.74.18.8732-8739.2000 – volume: 87 start-page: 4571 year: 2013 ident: 205_CR86 publication-title: J. Virol. doi: 10.1128/JVI.03443-12 – volume: 182 start-page: 6051 year: 2009 ident: 205_CR110 publication-title: J. Immunol. doi: 10.4049/jimmunol.0803965 – volume: 82 start-page: 2727 year: 2008 ident: 205_CR168 publication-title: J. Virol. doi: 10.1128/JVI.01990-07 – volume: 9 start-page: 553 year: 2002 ident: 205_CR72 publication-title: Nat. Struct. Biol. – volume: 28 start-page: 1061 year: 2017 ident: 205_CR117 publication-title: Hum. Gene Ther. doi: 10.1089/hum.2017.150 – volume: 10 start-page: 291 year: 2018 ident: 205_CR96 publication-title: Mol. Ther. Methods Clin. Dev. doi: 10.1016/j.omtm.2018.08.001 – volume: 365 start-page: 2357 year: 2011 ident: 205_CR28 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1108046 – volume: 14 year: 2018 ident: 205_CR122 publication-title: PLOS Pathog. doi: 10.1371/journal.ppat.1006929 – volume: 86 start-page: 8078 year: 1989 ident: 205_CR53 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.86.20.8078 – volume: 9 start-page: 844 year: 2018 ident: 205_CR129 publication-title: Vivo. Front. Immunol. doi: 10.3389/fimmu.2018.00844 – volume: 24 start-page: 94 year: 2015 ident: 205_CR17 publication-title: Curr. Opin. Pharmacol. doi: 10.1016/j.coph.2015.08.002 – volume: 363 start-page: 1429 year: 2010 ident: 205_CR24 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1000228 – volume: 21 start-page: 2205 year: 2013 ident: 205_CR50 publication-title: Mol. Ther. doi: 10.1038/mt.2013.184 – volume: 176 start-page: 71 year: 2018 ident: 205_CR100 publication-title: Biomaterials doi: 10.1016/j.biomaterials.2018.05.041 – volume: 372 start-page: 1920 year: 2015 ident: 205_CR171 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1412965 – volume: 286 start-page: 415 year: 2018 ident: 205_CR95 publication-title: J. Control Rel. doi: 10.1016/j.jconrel.2018.08.018 – volume: 28 start-page: 392 year: 2017 ident: 205_CR38 publication-title: Hum. Gene Ther. doi: 10.1089/hum.2016.128 – volume: 123 start-page: 2994 year: 2013 ident: 205_CR113 publication-title: J. Clin. Invest. doi: 10.1172/JCI68205 – volume: 34 start-page: 204 year: 2016 ident: 205_CR75 publication-title: Nat. Biotechnol. doi: 10.1038/nbt.3440 – volume: 16 start-page: 124 year: 2008 ident: 205_CR51 publication-title: Mol. Ther. doi: 10.1038/sj.mt.6300322 – volume: 8 start-page: 911 year: 2003 ident: 205_CR36 publication-title: Mol. Ther. doi: 10.1016/j.ymthe.2003.08.021 – volume: 18 start-page: 681 year: 2018 ident: 205_CR179 publication-title: Expert Opin. Biol. Ther. doi: 10.1080/14712598.2018.1479739 – volume: 16 start-page: 280 year: 2008 ident: 205_CR23 publication-title: Mol. Ther. doi: 10.1038/sj.mt.6300355 – volume: 262 start-page: 348 year: 2017 ident: 205_CR83 publication-title: J. Control Rel. doi: 10.1016/j.jconrel.2017.08.005 – volume: 23 start-page: 1877 year: 2015 ident: 205_CR159 publication-title: Mol. Ther. doi: 10.1038/mt.2015.179 – volume: 21 start-page: 1040 year: 2003 ident: 205_CR66 publication-title: Nat. Biotechnol. doi: 10.1038/nbt856 – volume: 19 start-page: 671 year: 2018 ident: 205_CR165 publication-title: Nat. Rev. Genet. doi: 10.1038/s41576-018-0051-9 – volume: 17 start-page: 1235 year: 2017 ident: 205_CR1 publication-title: Expert. Opin. Biol. Ther. doi: 10.1080/14712598.2017.1356817 – volume: 89 start-page: 1794 year: 2015 ident: 205_CR119 publication-title: J. Virol. doi: 10.1128/JVI.02710-14 – volume: 23 start-page: 1800 year: 2015 ident: 205_CR162 publication-title: Mol. Ther. doi: 10.1038/mt.2015.206 – volume: 24 start-page: 1042 year: 2016 ident: 205_CR160 publication-title: Mol. Ther. doi: 10.1038/mt.2016.61 – volume: 35 start-page: 264 year: 2017 ident: 205_CR81 publication-title: Nat. Biotechnol. doi: 10.1038/nbt.3801 – volume: 24 start-page: 198 year: 2006 ident: 205_CR70 publication-title: Nat. Biotechnol. doi: 10.1038/nbt1182 – volume: 18 start-page: 2048 year: 2010 ident: 205_CR61 publication-title: Mol. Ther. doi: 10.1038/mt.2010.172 – volume: 22 start-page: 1605 year: 2014 ident: 205_CR40 publication-title: Mol. Ther. doi: 10.1038/mt.2014.114 – volume: 24 start-page: 1050 year: 2016 ident: 205_CR67 publication-title: Mol. Ther. doi: 10.1038/mt.2016.62 – volume: 79 start-page: 5296 year: 2005 ident: 205_CR21 publication-title: J. Virol. doi: 10.1128/JVI.79.9.5296-5303.2005 – volume: 14 start-page: 97 year: 2006 ident: 205_CR147 publication-title: Mol. Ther. doi: 10.1016/j.ymthe.2006.02.014 – volume: 26 start-page: 334 year: 2015 ident: 205_CR39 publication-title: Hum. Gene Ther. doi: 10.1089/hum.2015.001 – volume: 430 start-page: 2626 year: 2018 ident: 205_CR56 publication-title: J. Mol. Biol. doi: 10.1016/j.jmb.2018.05.022 – volume: 20 start-page: R2 year: 2011 ident: 205_CR133 publication-title: Hum. Mol. Genet. doi: 10.1093/hmg/ddr141 – volume: 22 start-page: 934 year: 2015 ident: 205_CR78 publication-title: Gene Ther. doi: 10.1038/gt.2015.74 – volume: 8 start-page: 166 year: 2018 ident: 205_CR135 publication-title: Mol. Ther. Methods Clin. Dev. doi: 10.1016/j.omtm.2018.01.002 – volume: 29 start-page: 160 year: 2018 ident: 205_CR185 publication-title: Hum. Gene Ther. doi: 10.1089/hum.2017.218 – volume: 117 start-page: 6459 year: 2011 ident: 205_CR112 publication-title: Blood doi: 10.1182/blood-2010-10-314518 – volume: 372 start-page: 1887 year: 2015 ident: 205_CR170 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1414221 – volume: 24 start-page: 59 year: 2013 ident: 205_CR116 publication-title: Hum. Gene Ther. Methods doi: 10.1089/hgtb.2012.243 – volume: 6 start-page: 613 year: 1997 ident: 205_CR105 publication-title: Immunity doi: 10.1016/S1074-7613(00)80349-0 – volume: 140 start-page: 183 year: 2007 ident: 205_CR150 publication-title: J. Virol. Methods doi: 10.1016/j.jviromet.2006.11.019 – volume: 5 start-page: 1 year: 2013 ident: 205_CR8 publication-title: EMBO Mol. Med. doi: 10.1002/emmm.201202291 – volume: 20 start-page: 443 year: 2012 ident: 205_CR46 publication-title: Mol. Ther. doi: 10.1038/mt.2011.237 – volume: 26 start-page: 2337 year: 2018 ident: 205_CR178 publication-title: Mol. Ther. doi: 10.1016/j.ymthe.2018.07.011 – volume: 36 start-page: 29 year: 2018 ident: 205_CR26 publication-title: Pharm. Res. doi: 10.1007/s11095-018-2554-7 – volume: 9 start-page: 119 year: 2018 ident: 205_CR97 publication-title: Mol. Ther. Methods Clin. Dev. doi: 10.1016/j.omtm.2018.02.003 – volume: 25 start-page: 2648 year: 2017 ident: 205_CR115 publication-title: Mol. Ther. doi: 10.1016/j.ymthe.2017.08.018 – volume: 260 start-page: 649 year: 1996 ident: 205_CR43 publication-title: J. Mol. Biol. doi: 10.1006/jmbi.1996.0428 – volume: 11 start-page: 40 year: 2018 ident: 205_CR141 publication-title: Mol. Ther. Methods Clin. Dev. doi: 10.1016/j.omtm.2018.09.005 – volume: 31 start-page: 741 year: 2013 ident: 205_CR166 publication-title: Nat. Biotechnol. doi: 10.1038/nbt.2643 – volume: 20 start-page: 1831 year: 2012 ident: 205_CR9 publication-title: Mol. Ther. doi: 10.1038/mt.2012.194 – volume: 4 start-page: 372 year: 2001 ident: 205_CR144 publication-title: Mol. Ther. doi: 10.1006/mthe.2001.0462 – volume: 114 start-page: E4812 year: 2017 ident: 205_CR123 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1704766114 – volume: 26 start-page: 457 year: 2018 ident: 205_CR114 publication-title: Mol. Ther. – ident: 205_CR121 doi: 10.1128/JVI.01394-18 – volume: 18 start-page: 1907 year: 2010 ident: 205_CR84 publication-title: Mol. Ther. doi: 10.1038/mt.2010.170 – volume: 518 start-page: 95 year: 2018 ident: 205_CR94 publication-title: Virology doi: 10.1016/j.virol.2018.02.007 – volume: 121 start-page: 2224 year: 2013 ident: 205_CR131 publication-title: Blood doi: 10.1182/blood-2012-10-460733 – year: 2017 ident: 205_CR142 publication-title: J. Virol. doi: 10.1128/JVI.00710-17 – volume: 665 start-page: 182 year: 2018 ident: 205_CR153 publication-title: Neurosci. Lett. doi: 10.1016/j.neulet.2017.11.049 – volume: 28 start-page: 654 year: 2017 ident: 205_CR103 publication-title: Hum. Gene Ther. doi: 10.1089/hum.2017.016 – volume: 6 start-page: 973 year: 1999 ident: 205_CR143 publication-title: Gene Ther. doi: 10.1038/sj.gt.3300938 – volume: 80 start-page: 11556 year: 2006 ident: 205_CR16 publication-title: J. Virol. doi: 10.1128/JVI.01536-06 – volume: 1 start-page: 12 year: 2014 ident: 205_CR99 publication-title: Mol. Ther. Methods Clin. Dev. doi: 10.1038/mtm.2013.12 – volume: 378 start-page: 439 year: 2018 ident: 205_CR11 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1709866 – volume: 377 start-page: 2215 year: 2017 ident: 205_CR25 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1708538 – volume: 106 start-page: 10770 year: 2009 ident: 205_CR101 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.0902269106 – volume: 19 start-page: 1070 year: 2011 ident: 205_CR71 publication-title: Mol. Ther. doi: 10.1038/mt.2011.22 – volume: 23 start-page: 3180 year: 2014 ident: 205_CR163 publication-title: Hum. Mol. Genet. doi: 10.1093/hmg/ddu028 – volume: 10 start-page: 2112 year: 2003 ident: 205_CR35 publication-title: Gene Ther. doi: 10.1038/sj.gt.3302134 – volume: 12 start-page: 187 year: 2017 ident: 205_CR164 publication-title: Annu. Rev. Pathol. doi: 10.1146/annurev-pathol-052016-100332 – volume: 377 start-page: 2519 year: 2017 ident: 205_CR30 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1708483 – volume: 25 start-page: 2661 year: 2017 ident: 205_CR138 publication-title: Mol. Ther. doi: 10.1016/j.ymthe.2017.08.003 – volume: 14 start-page: 77 year: 2019 ident: 205_CR90 publication-title: Mol. Ther. Methods Clin. Dev. doi: 10.1016/j.omtm.2019.05.012 – volume: 86 start-page: 6620 year: 2012 ident: 205_CR91 publication-title: J. Virol. doi: 10.1128/JVI.00297-12 – volume: 9 start-page: 234 year: 2018 ident: 205_CR58 publication-title: Mol. Ther. Methods Clin. Dev. doi: 10.1016/j.omtm.2018.03.004 – volume: 6 start-page: 601 year: 2019 ident: 205_CR12 publication-title: Annu. Rev. Virol. doi: 10.1146/annurev-virology-092818-015530 – volume: 107 start-page: 2653 year: 2006 ident: 205_CR31 publication-title: Blood doi: 10.1182/blood-2005-10-4035 – volume: 123 start-page: 1390 year: 2013 ident: 205_CR128 publication-title: J. Clin. Invest. doi: 10.1172/JCI66611 – volume: 35 start-page: 280 year: 2017 ident: 205_CR80 publication-title: Nat. Biotechnol. doi: 10.1038/nbt.3781 – volume: 24 start-page: 287 year: 2016 ident: 205_CR134 publication-title: Mol. Ther. doi: 10.1038/mt.2015.187 – volume: 27 start-page: 143 year: 2016 ident: 205_CR62 publication-title: Hum. Gene Ther. Methods doi: 10.1089/hgtb.2016.054 – volume: 24 start-page: 53 year: 2016 ident: 205_CR126 publication-title: Mol. Ther. doi: 10.1038/mt.2015.134 – volume: 123 start-page: 601 year: 2018 ident: 205_CR180 publication-title: Circ. Res. doi: 10.1161/CIRCRESAHA.118.311587 – volume: 506 start-page: 382 year: 2014 ident: 205_CR157 publication-title: Nature doi: 10.1038/nature12875 – volume: 25 start-page: 1387 year: 2017 ident: 205_CR182 publication-title: Mol. Ther. doi: 10.1016/j.ymthe.2017.03.029 – volume: 12 start-page: 202 year: 2019 ident: 205_CR52 publication-title: Mol. Ther. Methods Clin. Dev. doi: 10.1016/j.omtm.2019.01.003 – volume: 12 start-page: 1056 year: 2015 ident: 205_CR79 publication-title: Cell Rep. doi: 10.1016/j.celrep.2015.07.019 – volume: 20 start-page: 1172 year: 2017 ident: 205_CR76 publication-title: Nat. Neurosci. doi: 10.1038/nn.4593 – volume: 119 start-page: 2388 year: 2009 ident: 205_CR111 publication-title: J. Clin. Invest. doi: 10.1172/JCI37607 – volume: 24 start-page: 49 year: 2017 ident: 205_CR93 publication-title: Gene Ther. doi: 10.1038/gt.2016.75 – volume: 387 start-page: 1178 year: 2016 ident: 205_CR181 publication-title: Lancet doi: 10.1016/S0140-6736(16)00082-9 – volume: 166 start-page: 263 year: 2016 ident: 205_CR187 publication-title: Cell doi: 10.1016/j.cell.2016.06.049 – volume: 132 start-page: 777 year: 2018 ident: 205_CR189 publication-title: Blood doi: 10.1182/blood-2018-04-839217 – volume: 19 start-page: 1971 year: 2011 ident: 205_CR98 publication-title: Mol. Ther. doi: 10.1038/mt.2011.157 – volume: 27 start-page: 601 year: 2018 ident: 205_CR107 publication-title: Hum. Mol. Genet. doi: 10.1093/hmg/ddx427 – volume: 23 start-page: 43 year: 2015 ident: 205_CR41 publication-title: Mol. Ther. doi: 10.1038/mt.2014.178 – volume: 377 start-page: 1713 year: 2017 ident: 205_CR37 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1706198 – volume: 24 start-page: 1519 year: 2018 ident: 205_CR54 publication-title: Nat. Med. doi: 10.1038/s41591-018-0209-1 – volume: 25 start-page: 212 year: 2014 ident: 205_CR137 publication-title: Hum. Gene Ther. doi: 10.1089/hum.2013.184 – volume: 79 start-page: 2528 year: 2005 ident: 205_CR20 publication-title: J. Virol. doi: 10.1128/JVI.79.4.2528-2540.2005 – volume: 27 start-page: 1285 year: 2018 ident: 205_CR3 publication-title: Heart Lung Circ. doi: 10.1016/j.hlc.2018.03.005 – volume: 109 start-page: 513 year: 2004 ident: 205_CR63 publication-title: Circulation doi: 10.1161/01.CIR.0000109697.68832.5D – volume: 26 start-page: 504 year: 2019 ident: 205_CR161 publication-title: Gene Ther. doi: 10.1038/s41434-019-0104-5 – volume: 8 start-page: 1307 year: 2006 ident: 205_CR124 publication-title: J. Gene Med. doi: 10.1002/jgm.967 – volume: 65 start-page: 776 year: 2016 ident: 205_CR183 publication-title: J. Hepatol. doi: 10.1016/j.jhep.2016.05.012 – volume: 50 start-page: 567 year: 2019 ident: 205_CR2 publication-title: Immunity doi: 10.1016/j.immuni.2019.02.005 – volume: 15 start-page: 445 year: 2014 ident: 205_CR18 publication-title: Nat. Rev. Genet. doi: 10.1038/nrg3742 – volume: 11 start-page: 493 year: 2009 ident: 205_CR104 publication-title: Curr. Opin. Mol. Ther. – volume: 57 start-page: 3509 year: 2016 ident: 205_CR167 publication-title: Invest. Ophthalmol. Vis. Sci. doi: 10.1167/iovs.16-19087 – volume: 12 start-page: 316 year: 2011 ident: 205_CR7 publication-title: Nat. Rev. Genet. doi: 10.1038/nrg2971 – volume: 8 start-page: 609 year: 2016 ident: 205_CR69 publication-title: EMBO Mol. Med. doi: 10.15252/emmm.201506078 – volume: 23 start-page: 1867 year: 2015 ident: 205_CR158 publication-title: Mol. Ther. doi: 10.1038/mt.2015.174 – volume: 4 start-page: 43 year: 2017 ident: 205_CR184 publication-title: Genes Dis. doi: 10.1016/j.gendis.2017.04.001 – volume: 17 start-page: 767 year: 2018 ident: 205_CR34 publication-title: Nat. Rev. Drug. Discov. doi: 10.1038/nrd.2018.158 – volume: 19 start-page: 800 year: 2012 ident: 205_CR68 publication-title: Gene Ther. doi: 10.1038/gt.2011.143 – volume: 99 start-page: 10405 year: 2002 ident: 205_CR15 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.162250899 – volume: 25 start-page: 415 year: 2018 ident: 205_CR139 publication-title: Gene Ther. doi: 10.1038/s41434-018-0034-7 – volume: 35 start-page: 691 year: 2017 ident: 205_CR188 publication-title: Nat. Biotechnol. doi: 10.1038/nbt0817-691 – volume: 87 start-page: 10784 year: 2013 ident: 205_CR92 publication-title: J. Virol. doi: 10.1128/JVI.01813-13 – volume: 7 start-page: 146 year: 2017 ident: 205_CR140 publication-title: Mol. Ther. Methods Clin. Dev. doi: 10.1016/j.omtm.2017.11.002 – volume: 431 start-page: 40 year: 2012 ident: 205_CR118 publication-title: Virology doi: 10.1016/j.virol.2012.05.004 – volume: 5 start-page: 194ra192 year: 2013 ident: 205_CR151 publication-title: Sci. Transl Med. doi: 10.1126/scitranslmed.3005795 – volume: 4 start-page: 165ra163 year: 2012 ident: 205_CR177 publication-title: Sci. Transl Med. doi: 10.1126/scitranslmed.3003454 – volume: 17 start-page: 1888 year: 2009 ident: 205_CR146 publication-title: Mol. Ther. doi: 10.1038/mt.2009.128 – volume: 5 start-page: 189ra176 year: 2013 ident: 205_CR77 publication-title: Sci. Transl Med. doi: 10.1126/scitranslmed.3005708 – volume: 9 start-page: 57 year: 2018 ident: 205_CR45 publication-title: Mol. Ther. Methods Clin. Dev. doi: 10.1016/j.omtm.2018.01.004 – volume: 20 start-page: 767 year: 2009 ident: 205_CR109 publication-title: Hum. Gene Ther. doi: 10.1089/hum.2008.161 – volume: 133 start-page: 407 year: 2019 ident: 205_CR173 publication-title: Blood doi: 10.1182/blood-2018-07-820720 – volume: 24 start-page: 545 year: 2013 ident: 205_CR32 publication-title: Hum. Gene Ther. doi: 10.1089/hum.2013.065 – volume: 6 start-page: 42 year: 2018 ident: 205_CR6 publication-title: Diseases doi: 10.3390/diseases6020042 – volume: 9 start-page: 737 year: 2017 ident: 205_CR10 publication-title: EMBO Mol. Med. doi: 10.15252/emmm.201707573 – volume: 82 start-page: 5887 year: 2008 ident: 205_CR125 publication-title: J. Virol. doi: 10.1128/JVI.00254-08 – volume: 371 start-page: 1994 year: 2014 ident: 205_CR27 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1407309 – volume: 3 year: 2018 ident: 205_CR33 publication-title: JCI Insight doi: 10.1172/jci.insight.120474 – volume: 359 year: 2018 ident: 205_CR4 publication-title: Science doi: 10.1126/science.aan4672 – volume: 1 start-page: 265 year: 2017 ident: 205_CR176 publication-title: Lancet. Child. Adolesc. Health doi: 10.1016/S2352-4642(17)30125-6 – volume: 5 start-page: 31 year: 2010 ident: 205_CR65 publication-title: Gene Ther. Regul. doi: 10.1142/S1568558610000197 – volume: 22 start-page: 1900 year: 2014 ident: 205_CR74 publication-title: Mol. Ther. doi: 10.1038/mt.2014.139 – volume: 12 start-page: 342 year: 2006 ident: 205_CR29 publication-title: Nat. Med. doi: 10.1038/nm1358 – volume: 86 start-page: 7752 year: 2012 ident: 205_CR120 publication-title: J. Virol. doi: 10.1128/JVI.00675-12 – volume: 17 start-page: 641 year: 2018 ident: 205_CR175 publication-title: Nat. Rev. Drug. Discov. doi: 10.1038/nrd.2018.110 – volume: 87 start-page: 13035 year: 2013 ident: 205_CR85 publication-title: J. Virol. doi: 10.1128/JVI.01826-13 – volume: 18 start-page: 37 year: 2018 ident: 205_CR169 publication-title: Expert. Opin. Biol. Ther. doi: 10.1080/14712598.2018.1389886 – volume: 15 start-page: 3247 year: 1996 ident: 205_CR106 publication-title: EMBO J. doi: 10.1002/j.1460-2075.1996.tb00689.x – volume: 24 start-page: 104 year: 2013 ident: 205_CR130 publication-title: Hum. Gene Ther. Methods doi: 10.1089/hgtb.2012.195 – volume: 24 start-page: 124 year: 2017 ident: 205_CR19 publication-title: Curr. Opin. Virol. doi: 10.1016/j.coviro.2017.06.003 – volume: 11 year: 2019 ident: 205_CR55 publication-title: Sci. Transl Med. doi: 10.1126/scitranslmed.aav4523 – volume: 3 start-page: 964 year: 2001 ident: 205_CR64 publication-title: Mol. Ther. doi: 10.1006/mthe.2001.0345 – volume: 105 start-page: 7827 year: 2008 ident: 205_CR59 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.0802866105 – volume: 29 start-page: 886 year: 2018 ident: 205_CR89 publication-title: Hum. Gene Ther. doi: 10.1089/hum.2017.220 – volume: 260 start-page: 805 year: 1976 ident: 205_CR42 publication-title: Nature doi: 10.1038/260805a0 – volume: 26 start-page: 289 year: 2018 ident: 205_CR127 publication-title: Mol. Ther. doi: 10.1016/j.ymthe.2017.09.021 – volume: 10 start-page: 257 year: 2018 ident: 205_CR102 publication-title: Mol. Ther. Methods Clin. Dev. doi: 10.1016/j.omtm.2018.07.011 – volume: 2 start-page: 15040 year: 2015 ident: 205_CR149 publication-title: Mol. Ther. Methods Clin. Dev. doi: 10.1038/mtm.2015.40 – volume: 25 start-page: 98 year: 2014 ident: 205_CR49 publication-title: Hum. Gene Ther. doi: 10.1089/hum.2013.164 – volume: 291 start-page: 939 year: 2016 ident: 205_CR88 publication-title: J. Biol. Chem. doi: 10.1074/jbc.M115.687657 – volume: 28 start-page: 350 year: 2017 ident: 205_CR136 publication-title: Hum. Gene Ther. doi: 10.1089/hum.2017.042 – volume: 1382 start-page: 21 year: 2016 ident: 205_CR48 publication-title: Methods Mol. Biol. doi: 10.1007/978-1-4939-3271-9_2 – volume: 4 year: 2019 ident: 205_CR108 publication-title: JCI Insight doi: 10.1172/jci.insight.99052 – volume: 3 start-page: 166 year: 2018 ident: 205_CR132 publication-title: Bioeng. Transl Med. doi: 10.1002/btm2.10090 – volume: 26 start-page: 304 year: 2018 ident: 205_CR73 publication-title: Mol. Ther. doi: 10.1016/j.ymthe.2017.09.006 – volume: 14 start-page: 316 year: 2006 ident: 205_CR13 publication-title: Mol. Ther. doi: 10.1016/j.ymthe.2006.05.009 – volume: 9 start-page: 2745 year: 1998 ident: 205_CR145 publication-title: Hum. Gene Ther. doi: 10.1089/hum.1998.9.18-2745 – volume: 9 start-page: 33 year: 2018 ident: 205_CR152 publication-title: Mol. Ther. Methods Clin. Dev. doi: 10.1016/j.omtm.2017.12.004 – volume: 189 start-page: 43 year: 2018 ident: 205_CR186 publication-title: Clin. Immunol. doi: 10.1016/j.clim.2017.07.006 – volume: 19 start-page: 1999 year: 2011 ident: 205_CR156 publication-title: Mol. Ther. doi: 10.1038/mt.2011.119 |
| SSID | ssj0016173 |
| Score | 2.7274716 |
| SecondaryResourceType | review_article |
| Snippet | Adeno-associated virus (AAV) vector-mediated gene delivery was recently approved for the treatment of inherited blindness and spinal muscular atrophy, and... |
| SourceID | proquest gale pubmed crossref springer |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 255 |
| SubjectTerms | 631/1647/1511 631/208/199 631/208/2489/201 631/61/2300/1514 Adaptive Immunity Agriculture Animal Genetics and Genomics Biomedical and Life Sciences Biomedicine Blindness Cancer Research Control Dependovirus - genetics Dependoviruses Duchenne's muscular dystrophy Expression vectors Gene Function Gene therapy Gene transfer Genetic aspects Genetic Engineering Genetic research Genetic Therapy Genetic vectors Genetic Vectors - immunology Health aspects Hemophilia Human Genetics Immune response Immunity, Innate Muscular dystrophy Neuromuscular diseases Rare diseases Review Article Spinal muscular atrophy Tropism Vectors (Biology) |
| Title | Engineering adeno-associated virus vectors for gene therapy |
| URI | https://link.springer.com/article/10.1038/s41576-019-0205-4 https://www.ncbi.nlm.nih.gov/pubmed/32042148 https://www.proquest.com/docview/2379540166 https://www.proquest.com/docview/2474986344 https://www.proquest.com/docview/2353581809 |
| Volume | 21 |
| WOSCitedRecordID | wos000512525800001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVPQU databaseName: Nursing & Allied Health Database customDbUrl: eissn: 1471-0064 dateEnd: 20241213 omitProxy: false ssIdentifier: ssj0016173 issn: 1471-0056 databaseCode: 7RV dateStart: 20001001 isFulltext: true titleUrlDefault: https://search.proquest.com/nahs providerName: ProQuest |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpR1daxQxMNhWoS9-f5zWcxVBUEIvm-wmwQeppUVBjuPUcm8hm2SlUHbr7d1B_72TbHbbLdoXX_KSSUgyk_nITGYQelsQqkGSGpxmqcbMUoNB7hRYps6VGqwxGYrBnHzj06lYLOQsPrg1Mayy44mBUdva-Dfy_ZRyCdoFyfNP57-xrxrlvauxhMYW2vFZEtIQujfrvQh562EmwICxz3nZeTWp2G9AcHFvS0sMClOG2UAuXefOV8TTNX9pEEPH9_53A_fR3aiAJgctxTxAt1z1EN1pS1JePEIfryQoTDQwpRrriEFnk83pct0km_DS3ySg7yZAfy5pP3FdPEY_j49-HH7BscACNpkUK6wNoc4VjOfcCm1LyUpOCmkEI6TUKdgypHDeoDGZcIQKbphlGTecW9ACUkOfoO2qrtwzlGTCaCI1pdaCQZcX2lgtrNNSWuYmjI3QpDteZWL2cV8E40wFLzgVqsWIAowojxEFQ973Q87b1Bs3Ab_yOFPt79H-2qqDHAyoDATwZITeBAif9KLyUTW_9Lpp1Nfv8wHQuwhU1rA8o-MnBdikz5M1gNwbQMKtNMPujgpU5AqNuiSBv3czzqTIqT-t1323n9gHwlWuXvspMp-xTkzkCD1tabI_HJoCBwbzdoQ-dER6Ofk_T-75zSt9gXZT_8QQgpX20PZquXYv0W2zWZ02yzHa4vMT3y54aAW04pCM0c7no-lsPg738Q93kDDj |
| linkProvider | ProQuest |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3db9QwDI_GAMEL34ODwQoCITFFuzZpkwghNA2mnXacEAy0t5AmKZqE2nG9O3T_FH8jdr-2TrC3PfAcJ0oT2z-7dmxCnqchM4CklkZxZCh3zFLAnZSqyPvMgDemqmYwX8diMpGHh-rjCvndvoXBtMpWJ1aK2hUW_5FvRUwosC7CJHl7_JNi1yiMrrYtNGq22PfLX-CylW9G7-B-X0TR7vuDnT3adBWgNlZyRo0NmfcpF4lw0rhM8UyEqbKSh2FmIjDgw9SjFW9j6UMmheWOx8IK4QD6Istg3UvkMlayQ4mSO11KCboKVUI_KHyKNTbbKCqTWyUApUDfXVEw0GLKezh4Fg1OweGZ-GwFe7s3_7cDu0VuNAZ2sF1LxG2y4vM75GrdcnN5l7w-VYAxMKB0C2oaDvUuWBxN52WwqCIZZQD2fADy5YP6kdryHvlyITtfI6t5kfsHJIilNaEyjDkHDmuSGuuMdN4o5bgfcj4gw_Y6tW2qq2OTjx-6ivIzqWsO0MABGjlAw5RX3ZTjurTIecQbyCO6fh3bqSW9nYCDGIOBMRyQZxUFFvXIMWvou5mXpR59_tQjetkQZQVsz5rmEQZ8JNYB61Gu9yhB69j-cMt1utF6pT5hub8Pc8GVTBie1tNuGBfGRL_cF3NcIsaKfHKoBuR-LQPd4bAIEAbc9wHZbIXiZPF_ntzD83e6Qa7tHXwY6_Fosv-IXI_wd0qVmLVOVmfTuX9MrtjF7KicPqlkPSDfLlpW_gAkzIfR |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1LbxMxEB6VFBAX3o9AoQsCIVFZya69a1sIoUIbEbWKovJQb67X9qJKKCnZJCh_jV_HeF_tVtBbD5w9trz2zHwzO-MZgJdpSDUiqSFRHGnCLDUEcSclMnIu0-iNyaIZzLd9PhqJw0M5XoPf9VsYn1ZZ68RCUdup8f_IexHlEq2LMEl6WZUWMd4ZvD_5SXwHKR9prdtplCyy51a_0H3L3w138K5fRdFg98vHT6TqMEBMLMWcaBNS51LGE26FtplkGQ9TaQQLw0xHaMyHqfMWvYmFC6nghlkWc8O5RRiMDMV1r8A6RyODdWD9w-5ofNDEMJIyvh2i-ie-4mYdU6WilyNscu_JS4LmWkxYCxXPY8MZcDwXrS1AcHDrfz6-23CzMr2D7VJW7sCam9yFa2UzztU9eHumNGOgUR1Pia5419lgeTxb5MGyiHHkAVr6AUqeC8rna6v78PVSdv4AOpPpxD2CIBZGh1JTai26skmqjdXCOi2lZa7PWBf69dUqU9Vd9-0_fqgi_k-FKrlBITcozw0Kp7xpppyURUcuIt70_KLKd7ONwlLbCbqOMZoe_S68KCh8uY-Jv_nvepHnavj5oEX0uiLKprg9o6vnGfiRvkJYi3KjRYn6yLSHaw5UlT7M1Sn7_X2YcSZFQv1pPW-G_cI-BXDipgu_ROxr9Ym-7MLDUh6aw6ERYg869l3YqgXkdPF_ntzji3e6CddRRNT-cLT3BG5E_j9LkbG1AZ35bOGewlWznB_ns2eV4AdwdNnC8gfG1pIv |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Engineering+adeno-associated+virus+vectors+for+gene+therapy&rft.jtitle=Nature+reviews.+Genetics&rft.au=Li%2C+Chengwen&rft.au=Samulski%2C+R+Jude&rft.date=2020-04-01&rft.eissn=1471-0064&rft.volume=21&rft.issue=4&rft.spage=255&rft_id=info:doi/10.1038%2Fs41576-019-0205-4&rft_id=info%3Apmid%2F32042148&rft.externalDocID=32042148 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-0056&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-0056&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-0056&client=summon |